////Çetin Volkan ÖZTEKİN

Çetin Volkan ÖZTEKİN

Doç. Dr.
Çetin Volkan ÖZTEKİN

  • Ana Bilim Dalı: Üroloji
  • 2014 TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Doçentlik
  • 2002 Üroloji TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Yardımcı Doçentlik
  • 2002 TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Doktora - Uzmanlık
  • Hacettepe Üniversitesi Tıp Fakültesi
    Yüksek Lisans
  • 1987-1990 Lise TED Ankara Koleji
  • 1974-1984 Orta TED Ankara Koleji
  • 1974-1984 İlk TED Ankara Koleji
  • Türk Üroloji Derneği
  • Ürolojik Cerrahi Derneği
  • Ankara Ürologlar Derneği
  • Endoüroloji Derneği
  • Üroonkoloji Derneği
ESERLER A. Uluslararası hakemli dergilerde yayımlanan makaleler :
  1. Aydos MM, Memiş A, Yakupoğlu YK, Özdal OL, Öztekin V, “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”, BJU Int, 88:382-384, 2001.
  2. Ozturk B, Cetinkaya M, Gur S, Ugurlu Ö, Öztekin V, Akı FT, “The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder”, Urol Res, 30:178-184, 2002. DOI:10.1007/s00240-002-0247-4
  3. Ozturk B, Cetinkaya M, Öztekin V, Inal G, Adsan O, Ugurlu O, Ozden C, “Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms”, Urol Int, 71:22-25, 2003. DOI:10.1159/000071088
  4. Öztekin ÇV, Ozturk B, Tas M, Ugurlu O, Cetinkaya M, “How do patients with familial benign prostatic hyperplasia differ clinically from those with sporadic benign prostatic hyperplasia?”, Urol Int, 76:332-334, 2006. DOI:10.1159/000092057
  5. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Öztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, Urology, 70(1):55-59, 2007. DOI:10.1016/j.urology. 2007.03.015
  6. Kosan M, Gonulalan U, Ugurlu O, Öztekin V, Akdemir O, Adsan O, “Testicular microlithiasis in patients with scrotal symptoms and its relationship to testicular tumors”, Urology, 70(6):1184-1186, 2007.  DOI:10.1016/j.urology.2007.07.049
  7.  Inal GH, Öztekin ÇV, Ugurlu O, Kosan M, Akdemir O, Cetinkaya M, “Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies”, Prostate Cancer Prostatic Dis, 11(3):270-273, 2008. DOI:10.1038/pcan.2008.34
  8. Ugurlu O, Cetinkaya M, Ozden C,Öztekin ÇV, Akdemir AO, Memis A, Yaris M, “An abnormal digital rectal examination is an independent predictor of high radical prostatectomy Gleason’s score (≥7) in patients with clinically localized prostate cancer”, Turk J Med Sci, 39(5):755-760, 2009. DOI:10.3906/sag-0807-1
  9. Ozden C, Öztekin ÇV, Ugurlu O, Gokkaya S, Yaris M, Memis A, “Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy”, Urol Int, 83:146-150, 2009. DOI:10.1159/000230014
  10. Ugurlu O, Yaris M, Öztekin ÇV, Kosan TM, Adsan O, Cetinkaya M, “Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: A prospective randomized controlled trial” Urol Int, 84:185-190, 2010. DOI:10.1159/000277596
  11. Akdemir AO, Ozden C, Öztekin ÇV, Aktas BK, Cetinkaya M, Memis A, Doluoglu OG, “Stage-by-Stage Effects of Surgical Margin Status on Biochemical Failure after Radical Prostatectomy in Patients with Clinically Localized Prostate Cancer”, Urol Int, 86:156-160, 2011.     DOI:10.1159/000322840
  12. Akdemir AO, Demirturk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Cetinkaya M, Gur S, Hellstrom JG, “Imatinib Mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue”, Urology, 78:968.e1-968.e6, 2011.    DOI:10.1016/j.urology.2011.06.033
  13. Memis A, Ugurlu O, Ozden C, Öztekin ÇV, Aktas BK, Akdemir AO, “The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy”, Kaohsiung J Med Sci, 27:307-313, 2011. DOI:10.1016/j.kjms.2011.03.009
  14. Akdemir AO, Öztekin ÇV, Doluoglu OG, Karabakan M, Ugurlu O, Cetinkaya M. “The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency.”, Ther Adv Urol, 4(2):51-56, 2012.   DOI:10.1177/1756287211435088
  15. Doluoglu OG, Gokkaya CS, Aktas BK, Öztekin ÇV, Bulut S, Memis A, Cetinkaya M, “Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P.”, Int Urol Nephrol, 44(4):1085-1090, 2012. DOI:10.1007/s11255-012-0127-y
  16. Öztekin ÇV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, Hellstrom WJ, “Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5-Alpha Reductase Inhibitor Therapy”, J Sex Med, 9(7):1773-1781, 2012.  DOI:10.1111/j.1743-6109.2012.02759.x
  17.  Postacı A, Aytaç İ, Öztekin ÇV, Dikmen B, “Acute unilateral parotid gland swelling after lateral decubitus position under general anesthesia”, Saudi J Anaesth, 6(3):307-309, 2012.DOI: 10.4103/1658-354X.101227
  18. Gökkaya CS, Öztekin ÇV, Özden C, Öztürk E, Aktaş BK, Memiş A, “Insulin resistance impairs response to doxazosin therapy in men with benign prostatic hyperplasia”, Turk J Med Sci, 43(1):1-5, 2013. DOI: 10.3906/sag-1203-90
  19. Öztekin ÇV, Gökkaya CS, Çiçekçioğlu H, Uçar Ö, Çetin M, Öztürk E, Memiş A, “Acute myocardial infarction without cardiogenic shock does not affect serum prostate spesific antigen levels: A case control study”, Int J Cardiol, 166(1):272-273, 2013. DOI: 10.1016/j.ijcard.2012.09.236
  20. Gökkaya CS,Özden C, Aktaş BK,Demirel HC, Güzel Ö, Karabakan M, Erkmen AE, Öztekin ÇV, Memiş A, “The Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms in Females”, Turk J Med Sci, 43(3):400-404, 2013. DOI: 10.3906/sag-1206-66 
  21. Öztekin ÇV, Gür S, Abdulkadir NA, Kartal M, Karabakan M, Akdemir AÖ, Gökkaya CS, Çetinkaya M, “Analysis of pomegranate juice components in rat corpora cavernosal relaxation”, Int J Impot Res, 2013.DOI:10.1038/ijir.2013.33 [1 Ağustos 2013 tarihinde online olarak yayınlanmıştır.]
  22. Doluoğlu ÖG, Saricaoğlu MS, Öztekin ÇV, Karakurt A, Akdemir AÖ, Koc E, “Cortical Blindness due to Bilateral Occipital Infarcts in a Renal Failure Patient with Prostate Cancer: A Rare Complication of Hemodialysis.”, Case Rep Med, 2013. DOI: 10.1155/2013/539761 [9 Ocak 2013 tarihinde online olarak yayınlanmıştır.]
  23. Ercan M, Akbulut ED, Abuşoğlu S, Yılmaz FM, Oğuz EF, Topçuoğlu C, Öztekin ÇV, Boğdaycıoğlu N. “Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to urinalysis.” Clin Biochem. 2015 May 27. pii: S0009-9120(15)00207-6. DOI:10.1016/j.clinbiochem.2015.05.016
B.Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler:
  1. Aydos M, Memiş A, Öztürk B, Ulusoy E, Öztekin V, Çetinkaya M, “Our end-to-end urethroplasty results for traumatic posterior urethral strictures”, 14th Congress of the European Association of Urology, Eur Urol, 35(suppl2):2, Stockholm, Sweden, Nisan, 1999.
  2. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Oztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, 21th Congress of the European Association of Urology, Eur Urol Suppl, 5(2):667, Paris, France, Nisan, 2006.
  3. Ugurlu O, Yaris M, OztekinCV, Kosan TM, Adsan O, Cetinkaya M, “Impact of antibacterial therapy on biopsy decision in the presence of prostatic inflammation in patients with prostate specific antigen levels between 2.5 and 10 ng/ml: A prospective randomized controlled trial”, 23rd Congress of the European Association of Urology, Eur Urol Suppl, 7(3):275, P17, Milan, Italy, Mart, 2008.
  4. Cetinkaya M, Oztekin CV, Ugurlu O, Yaris M, Lokman U, Adsan O, “The Relationship between sonographically measured prostatic indentation, prostatic urethral length and bladder-urethral angle and urodynamic bladder outlet obstruction parameters”, 24th Congress of the European Association of Urology, Eur Urol Suppl, 8(4):459, P29, Stockholm, Sweden, Mart, 2009.
  5. Doluoglu OG, Gokkaya CS, Aktas BK, Oztekin V, Bulut S, Memis A, Cetinkaya M, “Impact of pathologically proven prostatic inflamation on re-operation rates due to urethral or bladder neck strictures after transurethral resection of the prostate”, 26th Congress of the European Association of Urology, Eur Urol Suppl, 10(2):119, Vienna, Austria, Mart, 2011.
  6. Akdemir AO, Demirturk K, Karabakan M, Oztekin CV, Abdulkadir NA, Cetinkaya M, Gur S, "Imatinib Mesylate (Gleevec) as a protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue" AUA Annual Meting2011, J Urol 185(4S):630, Washington DC, ABD, Mayıs 2011
  7. Gökkaya C.S, Öztekin C.V, Özden C, Öztürk E, Aktaş B.K, Memiş A, "Isolated insulin resistance impairs response to doxasosin therapy in men with lower urinary tract symptoms due to BPH", 26th Congress of the European Association of Urology, Eur Urol Suppl, 10(2):120, Viyana, Avusturya, Mart 2011
  8. Gökkaya CS, Öztekin ÇV, Demirdal Ö, Gökkaya NK, Özden C, Uçan H, Memiş A, "Complete spinal cord lesions decrease prostate size without changing serum PSA levels. Are free PSA and PSA derivatives affected?", AUA Annual Meting, 2011, J Urol, 185(4S):697, Washington DC, ABD, Mayıs 2011
  9. Öztekin ÇV, Gökkaya CS, Çiçekçioğlu H, Uçar Ö, Çetin M, Öztürk E, Şahin M, Memiş A, "Acute Myocardial Infarction Without Cardiogenic Shock Does Not Affect Serum Prostate Specific Antigen Levels: A Case-Control Study.", 31st Congress of the SIU Urology, 78(Supp3A):327, Berlin, Almanya, Ekim 2011
  10. Gür S, şerefoglu EC, Öztekin ÇV, Lokman U, Un Ö, Gökkaya CS, Kadowitz PJ, Hellstrom WJG, “Silodosin (Kmd-3213) Is A Long-Acting Α-1a Adrenoceptor Antagonist With Activity In The Human Corpus Cavernosum.”, J Urol, 187(4): e331. (AUA Annual Meeting, Atlanta GA, ABD, 19-23 Mayıs 2012). DOI: http://dx.doi.org/10.1016/j.juro.2012.02.899
  11. Karabakan M, Akdemir S, Akdemir AÖ, Öztekin ÇV, Güzel Ö, Gökkaya CS, Çetinkaya M, “The Effect Of Ejaculation Frequency On Serum Prostate Spesific Antigen Level”, J Urol, 191(4):e 862.  (AUA Annual Meeting, Orlando FL, ABD, DOI: http://dx.doi.org/10.1016/j.juro.2014.02.2348
C. Yazılan uluslararası kitaplar veya kitaplarda bölümler : D. Ulusal hakemli dergilerde yayınlanan makaleler:
  1. Aydos M, Oral S, Öztürk B, Öztekin V, Akdemir Ö, Çetinkaya M, “Okul çağı çocuklardaki adolesan varikoselini tarama amaçlı yaptığımız saha çalışması sonuçlarımız”, Türk Üroloji Dergisi, 25(4), 430-435, 1999.
  2. Öztürk B, İnal G, Gökkaya S, Öztekin V, Memiş A, Çetinkaya M, “Erektil Disfonksiyonu Olan 127 Hastanın Nokturnal Penil Tümesans ve Rigidite Sonuçlarının Analizi”, Üroloji Bülteni, 12: 103-106, 2001.
  3. Öztekin ÇV, Akdemir AÖ, Doluoğlu ÖG, Uğurlu Ö, Sungur M, Çetinkaya M,  “Lokalize renal hücreli kanserlerde (pT≤2) renal kapsül infiltrasyonunun prognoz üzerine etkileri’’, Türk Üroloji Dergisi, 36(4):328-332, 2010. DOI:10.5152/tud.2010.039
  4. Doluoğlu ÖG, Öztekin ÇV, Uğurlu Ö. “Bosniak 3-4 renal kistlerde biyopsinin gereklilik ve sınırlamaları”, Üroonkoloji Bülteni, 3:40-42, 2010.
  5. Koşan M, Öztekin ÇV, “Olgu Sunumu: Mesane kanseri”, Üroonkoloji Bülteni, 1: 75-78, 2010.
  6. Uğurlu Ö, Öztekin V, Koşan M, Doluoğlu ÖG, Adsan Ö, Çetinkaya M, “Radikal sistoprostatektomi serimizde mesane tümörü ile prostat adenokarsinoma birlikteliğinin sağkalıma etkisi” J Clin Anal Med, 1(2): 1-4, 2010. DOI: 10.4328/JCAM.10.2.11
  7. Öztekin ÇV, Erşahin V. “İdame BCG kime uygulanmalı, nasıl uygulanmalı?”, Üroonkoloji Bülteni, 1:21-22, 2011.
  8. Mesut Çetinkaya, Öztekin ÇV. “Benign prostat hiperplazisi ve heredite”. Üroonkoloji bülteni 4:20-22, 2011.
  9. Gokkaya CS, Öztekin CV, Doluoglu OG, Guzel O, Ersahin V, Ozden C, Memis A. Validation of Turkish version of Bristol female lower urinary tract symptom index. J Clin Anal Med, 3(4):415-418, 2012. DOI: 10.4328/JCAM.814
  10. Demirel HC, Gökkaya CS, Özden Ö, Aktaş BK, Bulut S, Memiş A, Öztekin ÇV, “The risk factors for acute urinary retention in patients with benign prostatic hyperplasia”, Türk Üroloji Dergisi, 38(2):65-69, 2012.DOI:10.5152/tud.2012.016.
  11. Akdemir AÖ, Lokman U, Öztekin ÇV, Sungur M, Adsan Ö. “Transverse Testicular Ectopia In An Adult Male; A Rare Form of Persistent Mullerian Duct Syndrome: A Case Report.”, J Clin Anal Med, 4(2):143-145,2013, DOI: 10.4328/JCAM.627
  12. Çetinkaya M, Öztekin ÇV, “Prostat kanserinde Chemoprevention”, Üroloji Bülteni, [Yayına kabul tarihi: 19 Ocak 2012]
  13. Gökkaya CS, Öztekin ÇV, Demirdal Ö, Gökkaya NK, Özden C, Uçan H, Memiş A. “Prostate-Specific Antigen and its Derivatives in Spinal Cord Injured Patients; A Case-Control Study” J Clin Anal Med, 4(6):491-494,2013, DOI: 10.4328/JCAM.1108
  14. Doluoğlu ÖG, Öztekin ÇV, Karabakan M, Akdemir AÖ, Çetinkaya M. The importance of prostate volume in prostate needle biopsy. Turkish journal of urology. 2013;39(2):74-77. doi:10.5152/tud.2013.019.
  15. Özer G, Öztekin ÇV, Akdemir AÖ, Gökkaya CS. “Sünnet operasyonunda kanama kontrolü için radyofrekans kullanımının bipolar elektrokoterizasyon ve sütür ile bağlama yöntemleri ile karşılaştırılması”, J Turgut Özal Med Cent, 20(2):129-132,2013 [Çalışma basıma kabul edildiğinde İnönü Üniversitesi Tıp Fakültesi Dergisi olan derginin adı Journal of Turgut Özal Medical Center olarak değiştirilmiştir].
  16. Güzel Ö, Öztekin ÇV, Sungur, M, Uğurlu Ö, Doluoğlu ÖG, Yılmaz N, Çetinkaya M. Benign Prostat Hiperplazisinde Tolterodin ve Tamsulosin Kombinasyonunun Semptomlar ve Mesane Çıkım Obstrüksiyonu Üzerine Etkisi. İnönü Tıp Fakültesi Dergisi, 20(1):12-18
  17. Karabakan M, AkdemirAÖ, Öztekin ÇV , Özge Han , Serkan Akdemir, “İyi Diferansiye Skrotal Liposarkom”, İnönü Üniversitesi Sağlık Bilimleri Dergisi 2014; 3 (1): 43-44
  18. Karabakan M, Akdemir S, Akdemir AÖ, Öztekin ÇV , Güzel Ö, Gökkaya CS, Çetinkaya M. “The Effect of Ejaculation Frequency on Serum ProstateSpecific Antigen Level.” Journal of Academic research in medicine, 5:56-59,2015, DOI: 10.5152/jarem.2015.685
  19. Özer Güzel, Öztekin ÇV, Alp Özgür Akdemir, Mehmet Karabakan, Mesut Çetinkaya Giant Fecaloma Leading to Bilateral Ureterohydronephrosis Erciyes Med J 2015; 37(3): 110-2 • DOI: 10.5152/etd.2015.7161
E. Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler:  
  1. Aydos, M., Memiş, A., Öztürk, B., Ulusoy, E., Öztekin, V., Çetinkaya, M, "Travmatik posterior üretra darlıklarında end-to-end üretroplasti sonuçlarımız", 15. Ulusal Üroloji Kongresi konferansı dahilinde "15. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:66, Antalya, Türkiye, Ekim1998
  2. Öztürk, B., İnal, G., Gökkaya, S., Öztekin, V., Memiş, A., Çetinkaya, M, "Erektil Disfonksiyonu olan 127 hastanın Nokturnal Penil Tümesans ve Rigidite sonuçlarının analizi", 16. Ulusal Üroloji Kongresi konferansı dahilinde "16. Ulusal Üroloji Kongresi" bildiri kitapçığı, Sunum No: p-276, İzmir, Türkiye, Ekim 2000
  3. Adsan, Ö., Çetinkaya, M., Özden, C., Akı, T., Öztürk, B., Öztekin, V, "BPH nedeniyle opere edilen yüksek PSA’ lı hastaların erken takip sonuçları", 16. Ulusal Üroloji Kongresi konferansı dahilinde "16. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:166, İzmir, Türkiye, Ekim 2000
  4. Öztürk B, Gökkaya S, Akar E, Öztekin V, Koparal S, Çetinkaya M, "Tek olarak veya papaverin ile birlikte kullanılan sildenafilin erektil disfonksiyonu olan hastaların penil renkli doppler ultrason parametrelerine etkisi", 17. Ulusal Üroloji Kongresi konferansı dahilinde "17. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:237, Antalya, Türkiye, Ekim 2002
  5. Öztürk B, Çetinkaya M, Gür S, Uğurlu Ö, Öztekin V, İnal G, "Parsiyel çıkım obstrüksiyonun diyabetik ve diayabetik olmayan rat detrüsörü relaksasyonu üzerine erken etkileri", 17. Ulusal Üroloji Kongresi konferansı dahilinde "17. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:35, Antalya, Türkiye, Ekim 2002
  6. Uğurlu Ö, Gönülalan U, Adsan Ö, Koşan M, Öztekin V, Çetinkaya M, "BPH Ve Üç Santimetreden Küçük Tek Odaklı Yüzeyel Mesane Tümörlü Hastaların Aynı Seansda Transüretral Rezeksiyonla Tedavisinin Rekürrens Ve Progresyona Etkisi", 19. Ulusal Üroloji Kongresi konferansı dahilinde "19. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:178-179, Antalya, Türkiye, Haziran 2006
  7. Koşan M, Yariş M, Uğurlu Ö, Öztekin V, Adsan Ö, Çetinkaya M, "Lokalize Prostate Kanseri Nedeniyle Radikal Retropubik Prostatektomi Uygulanan Hastalarda Preoperatif PSA Parametrelerinin Progresyonla İlişkisi", 19. Ulusal Üroloji Kongresi konferansı dahilinde "19. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:346, Antalya, Türkiye, Haziran 2006
  8. Koşan M, Gönülalan U, Uğurlu Ö, Öztekin V, Akdemir Ö, Adsan Ö, "Skrotal Semptom İle Başvuran Hastalarda Testiküler Mikrolitiyazis Oranı Ve Testiküler Tümörle İlişkisi", 17. Ulusal Kanser Kongresi konferansı dahilinde "17. Ulusal Kanser Kongresi" bildiri kitapçığı, sayfa:59, Antalya, Türkiye, Nisan 2007
  9. Uğurlu Ö, Öztekin V, Koşan M, Doluoğlu Ö, Adsan Ö, Çetinkaya M, "Radikal Sistoprostatektomi Serimizde Mesane Tümörü İle Prostat Adeno Ca Birlikteliğinin Sağkalıma Etkisi", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:106, Ankara, Türkiye, Kasım 2007
  10. İnal G, Öztekin V, Uğurlu Ö, Koşan M, Akdemir AÖ, Çetinkaya M, "Prostat Biyopsilerinde Onaltı G İğne Kullanımının Kanser Yakalama Oranı Ve Örnek Doku Kalitesine Etkileri", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:49, Ankara, Türkiye, Kasım 2007
  11. Koşan M, Yariş M, Öztekin ÇV, Uğurlu Ö, Akdemir Ö, Çetinkaya M, "İleri Evre Prostat Kanseri Tedavisinde Steroidal Ve Non-Steroidal Antiandrojenlerin Serum Lipid Profiline Etkisi", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:91, Ankara, Türkiye, Kasım 2007
  12. Uğurlu Ö, Çetinkaya M, Özden C, Öztekin V, Akdemir Ö, Memiş A, Yariş M, "Klinik lokalize prostat kanserinde parmakla rektal muayene ve serbest/total PSA yüzdesi kullanılarak yüksek Gleason skoru öngörülebilir mi?", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:57, Ankara, Türkiye, Kasım 2007
  13. Akdemir Ö, Koşan M, Sungur M, Adsan Ö, Öztekin V, Çetinkaya M, "Lokalize Böbrek Tümörlerinde Tümörün Yerleşim Bölgesi İle Progresyonu Arasındaki İlişki", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:134, Ankara, Türkiye, Kasım 2007
  14. Çetinkaya M, Öztekin ÇV, Uğurlu Ö, Yariş M, Lokman U, Adsan Ö, "Transrektal ultrasonografi kullanılarak ölçülen prostatik indentasyon, prostatik üretra uzunluğu ve mesane-üretra açısı ile ürodinamik mesane çıkım obstrüksyonu parametrelerinin ilişkisi", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:474, Antalya, Türkiye, Kasım 2008
  15. Öztekin ÇV, Sungur M, Uğurlu Ö, Doluoğlu ÖG, Yılmaz N, Çetinkaya M, "Benign Prostat Hiperplazisine bağlı alt üriner sistem semptomlarının tedavisinde tolterodinin monoterapi ve tamsulosin ile kombine olarak kullanımının tamsulosin ile prospektif randomize olarak karşılaştırılması", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:144, Antalya, Türkiye, Kasım 2008
  16. Özden C, Öztekin ÇV, Uğurlu Ö, Gökkaya CS, Yariş M, Memiş A, “Radikal prostatektomi sonrası prostat biyopsisi gleason skor yükselmesi ile patolojik özellikler ve biyokimyasal başarısızlık arasındaki ilişki, 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:310, Antalya, Türkiye, Kasım 2008
  17. Ugurlu Ö, Yariş M, Öztekin ÇV, Koşan M, Adsan Ö, Çetinkaya M, "Prostat İnflamasyonu Varlığında Antibakteriyel ve Antiinflamatuar Tedavilerin Serum PSA Seviyelerine Etkisi: Prospektif Randomize Kontrollü Çalışma", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:90, Antalya, Türkiye, Kasım 2008
  18. Akdemir AO, Özden C, Öztekin CV, Aktaş BK, Çetinkaya M, Memiş A, "Klinik lokalize prostat kanserli hastalarda radikal retropubik prostatektomi sonrası cerrahi sınır pozitifliği ile biyokimyasal başarısızlık arasındaki ilişki", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:264-265, Ankara, Türkiye, Kasım 2009
  19. Öztekin ÇV, Akdemir AÖ, Uğurlu Ö, Kılınç R, Adsan Ö, Çetinkaya M, "Mesane kanseri olan hastalarda makroskopik hematüri varlığı ve ilk hematüri atağından sonra geçen sürenin prognostik faktörler ile ilişkileri", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:110, Ankara, Türkiye, Kasım 2009
  20. Akdemir AO, Özden C, Öztekin CV, Gökkaya CS, Çetinkaya M, Memiş A, "Preoperatif prostat biyopsisine göre radikal prostatektomi sonrası gleason skor yükselmesinin pozitif prostat biyopsi kor yüzdesi ile ilişkisi", 9.Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:262-263, Ankara, Türkiye, Kasım 2009
  21. Öztekin ÇV, Çetinkaya M, Akdemir AÖ, Uğurlu Ö, Baykal Y, Lokman U, "Benign Prostat Hiperplazisinde bağlı kalıcı üriner retansiyon gelişmesine etki eden faktörler", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:316, Ankara, Türkiye, Kasım 2009
  22. Öztekin ÇV, Uğurlu Ö, Sungur M, Akdemir AÖ, Doluoğlu ÖG, Çetinkaya M, "Retroperitoneal Laparoskopi Deneyimimiz: İlk 40 olgu", 8. Ulusal Endoüroloji Kongresi konferansı dahilinde "8. Ulusal Endoüroloji Kongresi" bildiri kitapçığı, sayfa:172, Antalya, Türkiye, Kasım 2009
  23. Akdemir AÖ, Demirtürk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Çetinkaya M, Gür S, "Bir Protein Tirozin Kinaz İnhibitörü Olan İmatinib Mesilat’ın (Gleevec) İzole İnsan Prostat Dokusu Üzerinde Düz Kas Gevşetici Etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:164-165, İstanbul, Türkiye, Ekim 2010
  24. Akdemir AÖ, Öztekin ÇV, Doluoğlu ÖG, Karabakan M, Uğurlu Ö, Çetinkaya M, "Hafif Serum Kreatinin Yüksekliği Olan (1.5-3 mg/dl) BPH’li Hastalarda TUR-P’nin Mortalite ve Morbiditeye Etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:32-33, İstanbul, Türkiye, Ekim 2010
  25.  Doluoğlu ÖG, Gökkaya CS, Aktaş BK, Öztekin ÇV, Bulut S, Memiş A, Çetinkaya M, "Transüretral prostat rezeksiyonu sonrası mesane boynu darlığı ve üretra darlığı gelişiminde prostat enflamasyonunun etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:30, İstanbul, Türkiye, Ekim 2010.
  26. Gökkaya CS, Aktaş BK, Öztekin ÇV, Salar R, Özden C, Memiş A, "Prostat İğne Biyopsisi Erken Dönemde Prostat Hacmini Veya Alt Üriner Sistem Semptomlarını Değiştiriyor mu?", 22.Ulusal Üroloji Kongresi konferansı dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:308-309, Girne, KKTC, Mayıs 2012
  27. Gökkaya CS, Özden C, Aktaş BK, Demirel HC, Güzel Ö, Karabakan M, Erkmen MA, Öztekin ÇV, Memiş A, "Kadınlarda Metabolik Sendrom ile Alt Üriner Sistem Semptomları Arasındaki İlişki", 22.Ulusal Üroloji Kongresi konferansı dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:18-19, Girne, KKTC, Mayıs 2012
  28. Doluoğlu ÖG, Öztekin ÇV, Karabakan M, Akdemir AÖ, Çetinkaya M, “Prostat İğne Biyopsisinde Prostat Volümünün Önemi”, 22.Ulusal Üroloji Kongresi dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:228, Girne, KKTC, Mayıs 2012
  29. Özer G, Öztekin ÇV, Akdemir AÖ, Gökkaya CS, 1.Ulusal Ürolojik Cerrahi Kongresi dahilinde “1.Ürolojik Cerrahi Kongresi” bildiri kitapçığındaki “Sünnet operasyonunda kanama kontrolü için radyofrekans kullanımının bipolar elektrokoterizasyon ve sütür ile bağlama yöntemleri ile karşılaştırılması”,  1. Ulusal Ürolojik Cerrahi Kongresi dahilinde 1.Ulusal Ürolojik Cerrahi Kongresi Bildiri Kitapçığı, sayfa:16, Antalya, Türkiye, Ekim 2012G. Atıflar
A1. Aydos MM, Memiş A, Yakupoğlu YK, Özdal OL, Öztekin V, “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”, BJU Int, 88:382-384, 2001.
  1. Lumen N, Spiers S, De Backer S, Pieters R, Oosterlinck W. “Assessment of the short-term functional outcome after urethroplasty: a prospective analysis.” Int Braz J Urol, 37(6):712-718, 2011.
  2. Johnson EK, Latini JM. “The impact of urethroplasty on voiding symptoms and sexual function.” Urology, 78(1):198-201. 2011.
  3. Cooperberg MR, McAninch JW, Alsikafi NF, Elliott SP. “Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience.” J Urol, 178(5):2006-2010, 2007.
  4. Osterberg EC, Gaither TW, Awad MA, Alwaal A, Erickson BA, McAninch JW, Breyer  BN. Current Practice Patterns Among Members of the American Urological Association for Male Genitourinary Lichen Sclerosus. Urology. 2016 Jun;92:127-31. doi: 10.1016/j.urology.2016.02.033.
  5. DeLong J, Buckley J. Patient-reported outcomes combined with objective data toevaluate outcomes after urethral reconstruction. Urology. 2013 Feb;81(2):432-6. doi: 10.1016/j.urology.2012.10.046.
  6. Wessels SG, Heyns CF. Prospective evaluation of a new visual prostate symptom  score, the international prostate symptom score, and uroflowmetry in men with urethral stricture disease. Urology. 2014 Jan;83(1):220-4. doi: 10.1016/j.urology.2013.08.058
  7. Hosseini J, Tavakkoli Tabassi K. Surgical repair of posterior urethral defects: review of literature and presentation of experiences. Urol J. 2008 Fall;5(4):215-22.
  8. Goonesinghe SK, Hillary CJ, Nicholson TR, Osman NI, Chapple CR. Flexible cystourethroscopy in the follow-up of posturethroplasty patients and characterisation of recurrences. Eur Urol. 2015 Sep;68(3):523-9. doi: 10.1016/j.eururo.2015.04.013
  9. Osterberg EC, Schulster M, Blaivas JG, Maganty A, Lee DJ, Purohit RS. Urethroplasty Improves Overactive Bladder Symptoms in Men With Anterior Urethral  Strictures. Urology. 2016 Jul;93:208-12. doi: 10.1016/j.urology.2016.04.003
  10. Heyns CF. Follow-up strategies after urethral stricture treatment in Advanced male Urethral and Genital Reconstructive Surgeryby Brandes SB, Morey AF., 2013 413-415. DOI:10.1007/978-1-4614-7708-2_28
  11. Zhao CL, Gonzales CM. The Use of Patient-Reported Outcome Measures in Men with Urethral Stricture Disease in in Advanced male Urethral and Genital Reconstructive Surgeryby Brandes SB, Morey AF. 2013; 435-448. DOI: 10.1007/978-1-4614-7708-2_30
  12. Ali S, Shahnawaz, Shahzad I, Baloch MU. Delayed Single Stage Perineal Posterior Urethroplasty. J Coll Physicians Surg Pak. 2015 Jun;25(6):438-42. doi: 06.2015/JCPSP.438442.
  13. Odoemene CA, Okere P. One-stage Anastomotic Urethroplasty for Traumatic Urethral Strictures. January 2004-January 2013. Niger J Surg. 2015 Jul-Dec;21(2):124-9. doi: 10.4103/1117-6806.162574.
A2. Ozturk B, Cetinkaya M, Gur S, Ugurlu Ö, Oztekin V, Akı FT, “The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder”, Urological Research, 30:178-184, 2002. DOI:10.1007/s00240-002-0247-4
  1. Michel MC, Barendrecht MM. “Physiological and pathological regulation of the autonomic control of urinary bladder contractility.” Pharmacol Ther, 117(3):297-312, 2008.
  2. Gur S, Irat AM. “L-carnitine treatment partially restores urinary bladder function of streptozotocin diabetic rats.” Urol Int, 81(3):340-346. 2008.
  3. Kosan M, Tul M, Ozturk B, Hafez G, Inal G, Cetinkaya M. “Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity.” Urol Int, 80(2):193-200, 2008.
  4. Su X, Changolkar A, Chacko S, Moreland RS. “Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chainphosphorylation.” Am J Physiol Renal Physiol, 287(4):F690-699, 2004.
  5. Longhurst PA, Levendusky MC, Bezuijen MW. “Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction.” J Urol, 171(2 Pt 1):933-937, 2004.
  6. Barendrecht MM, Chichester P, Michel MC, Levin RM. Effect of short-term outlet obstruction on rat bladder nerve density and contractility. Auton Autacoid Pharmacol. 2007 Jan;27(1):47-53.
  7. Hammad FT. Electrical propagation in the renal pelvis, ureter and bladder. Acta Physiol (Oxf). 2015 Feb;213(2):371-83. doi: 10.1111/apha.12392.
  8. Michishita M, Yano K, Kasahara K, Tomita K, Matsuzaki O. Increased expression of 5-HT(2A) and 5-HT(2B) receptors in detrusor muscle after partial bladderoutlet obstruction in rats. Biomed Res. 2015;36(3):187-94. doi: 10.2220/biomedres.36.187.
A3. Ozturk B, Cetinkaya M, Oztekin V, Inal G, Adsan O, Ugurlu O, Ozden C, “Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms”, Urol Int, 71: 22-25, 2003. DOI:10.1159/000071088
  1. Méndez-Rubio S, Chiarelli L, Salinas-Casado J, Cano S, Virseda-Chamorro M,Ramírez JC, Campanario F, Silmi-Moyano A. ["Post micturition residual; urodynamic"]. Actas Urol Esp, 34(4):365-371, 2010.
  2. Hinkel A, Noldus J, Palisaar R. “Urologic Emergencies in oncology.” Onkologe, 34(4):365-371, 2010.
  3. de Zeeuw S, van Mastrigt R. “Increased postvoid residual volume after measuring the isovolumetric bladder pressure using the noninvasive condom catheter method.” BJU Int, 100(6):1293-1297. 2007.
  4. van Mastrigt R, Pel JJ, Chung JW, de Zeeuw S. Development and application ofthe condom catheter method for non-invasive measurement of bladder pressure. Indian J Urol. 2009 Jan;25(1):99-104. doi: 10.4103/0970-1591.45546.
  5. Chandrapal j, Bowen RC, Patel DP, Le A, Hotaling JM, Southwick AW. High Rates of Inadequate Urine Volume Cause Failure of Clinic Based Uroflowmetry in Men with Lower Urinary Tract Symptoms. Urology Practice, 3(4):247-250. 2016. DOI:10.1016/j.urpr.2015.08.003
A5. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Oztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, Urology, 70(1):55-9, 2007. DOI:10.1016/j.urology. 2007.03.015
  1. Luo S, Lin Y, Zhang W. “Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis.” J Endourol, 25(2):291-296, 2011.
  2. Jaidane M, Bouicha T, Slama A, Hmida W, Hidoussi A, Ben Sorba N, Mosbah F. “Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.” Urology 75(6):1392-5, 2010.
  3. Singh V, Sinha RJ, Sankhwar SN. “Outcome of simultaneous transurethral resection of bladder tumor and transurethral resection of the prostate in comparison with the procedures in two separate sittings in patients with bladder tumor and urodynamically proven bladder outflow obstruction.” J Endourol, 23(12):2007-2011, 2009.
  4. Ham WS, Kim WT, Jeon HJ, Lee DH, Choi YD. “Long-term outcome of simultaneoustransurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.” J Urol, 181(4):1594-1599, 2009.
  5. Li Z, Hou R, Li J. The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms. Int Urol Nephrol April 2014, Volume 46, Issue 4, pp 691-694
  6. Li S, Zeng XT, Ruan XL, Wang XH, Guo Y, Yang ZH. Simultaneous transurethralresection of bladder cancer and prostate may reduce recurrence rates: Asystematic review and meta-analysis. Exp Ther Med. 2012 Oct;4(4):685-692
  7. Picozzi SC, Ricci C, Gaeta M, Casellato S, Bozzini G, Ratti D, Carmignani L. Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients. Int Urol Nephrol. 2012 Oct;44(5):1325-33. doi: 10.1007/s11255-012-0183-3.
  8. Park SH, Kim SI, Kim SJ.   Effects of Simultaneous Transurethral Resection of Non-Muscle-Invasive Bladder Cancer and Benign Prostatic Hyperplasia.   Korean J Urol. 2009 Jun;50(6):534-539.  DOI:10.4111/kju.2009.50.6.534
  9. Lee CH, Hwang TIS, Yeh CH. Simultaneous transurethral resection of a bladder tumor and benign prostatic hyperplasia: Four case reports and literature review.Urological Science. 2012 Mar; 23(1):31-33. DOI:10.1016/j.urols.2011.12.008
A6. Kosan M, Gonulalan U, Ugurlu O, Oztekin V, Akdemir O, Adsan O, “Testicular microlithiasis in patients with scrotal symptoms and its relationship to testicular tumors”, Urology, 70(6):1184-1186, 2007.  DOI:10.1016/j.urology.2007.07.049
  1. Tan IB, Ang KK, Ching BC, Mohan C, Toh CK, Tan MH. “Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review.” Cancer, 1;116(19):4520-4532, 2010.
  2. Aganovic L, Cassidy F. Imaging of the scrotum. Radiol Clin North Am. 2012Nov;50(6):1145-65. doi: 10.1016/j.rcl.2012.08.003.
  3. Richenberg J, Brejt N. Testicular microlithiasis: is there a need for surveillance in the absence of other risk factors? Eur Radiol. 2012 Nov;22(11):2540-6. doi: 10.1007/s00330-012-2520-4.
  4. Mullooly C, Hickerton B, Weston R, Woolley PD. Testicular microlithiasis: is it significant? Int J STD AIDS. 2012 Sep;23(9):620-2. doi: 10.1258/ijsa.2012.011444.
  5. Rahimi R, Foroughi AA, Haghpanah S, Bahmanyar M, Jelodari S, De Sanctis V, Karimi M. Incidence of testicular microlithiasis in patients with β-thalassemia major. Ann Hematol. 2015 Nov;94(11):1785-9. doi: 10.1007/s00277-015-2465-1.
  6. Baltogiannis D, Tsili A. Testicular microlithiasis: Clinical significance and review of the literature. Hell Urol. 2013; 27(3). DOI:10.19264/hj.v27i3.86
  7. Kühn AL, Scortegagna E, Nowitzki KM, Kim YH. Ultrasonography of the scrotum in adults. Ultrasonography. 2016 Jul;35(3):180-97. doi: 10.14366/usg.15075.
A7. Inal GH, Oztekin CV, Ugurlu O, Kosan M, Akdemir O, Cetinkaya M, “Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies”, Prostate Cancer Prostatic Dis, 11(3):270-3, 2008. DOI:10.1038/pcan.2008.34
  1. Fajardo DA, Epstein JI. “Fragmentation of prostatic needle biopsy cores containing adenocarcinoma: the role of specimen submission.”  BJU Int, 105(2):172-175, 2010.
  2. Fiset PO, Aprikian A, Brimo F. Length of prostate biopsy cores: does it impact cancer detection? Can J Urol. 2013 Aug;20(4):6848-53.
  3. McCormack M, Duclos A, Latour M, McCormack MH, Liberman D, Djahangirian O,Bergeron J, Valiquette L, Zorn K. Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial. Can Urol Assoc J. 2012 Apr;6(2):97-101. doi: 10.5489/cuaj.11169.
  4. Cicione A, Cantiello F, De Nunzio C, Tubaro A, Damiano R. Prostate biopsy quality is independent of needle size: a randomized single-center prospective study. Urol Int. 2012;89(1):57-60. doi: 10.1159/000339250.
  5. Durmus T, Goldmann U, Baur AD, Huppertz A, Schwenke C, Hamm B, Franiel T.MR-guided biopsy of the prostate: comparison of diagnostic specimen quality with 18 G and 16 G biopsy needles. Eur J Radiol. 2013 Dec;82(12):e749-54. doi: 10.1016/j.ejrad.2013.08.020.
  6. Lee S, Jeong SJ, Hwang SI, Hong SK, Lee HJ, Byun SS, Choe G, Lee SE. Clinical value of core length in contemporary multicore prostate biopsy. PLoS One. 2015Apr 14;10(4):e0123704. doi: 10.1371/journal.pone.0123704.
  7. Cicione A, Cantiello F, De Nunzio C, Tubaro A, Damiano R. Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link. Can Urol Assoc 2013 Sep-Oct;7(9-10):E567-71. doi: 10.5489/cuaj.311.
  8. Shida Y, Hakariya T, Takehara K, Onita T, Miyata Y, Sakai H. Comparison Between a Combined Transrectal and Transperineal Approach and a Transrectal Approach for Prostate Rebiopsy. Anticancer Res. 2016 Sep;36(9):4685-90.
  9. Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, WagenlehnerFM. Prostate Biopsy-related Infection: A Systematic Review of Risk Factors,Prevention Strategies, and Management Approaches. Urology. 2016 Dec 19. pii:S0090-4295(16)30953-0. doi: 10.1016/j.urology.2016.12.011.
A9. Ozden C, Oztekin CV, Ugurlu O, Gokkaya S, Yaris M, Memis A, “Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy”. Urol Int, 83:146-150, 2009. DOI:10.1159/000230014
  1. Lallas CD, Pe ML, Thumar AB, Chandrasekar T, Lee FC, McCue P, Gomella LG,Trabulsi EJ. “Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy.” BJU Int, 107(7):1136-1140, 2011.
  2. Colleselli D, Schilling D, Lichy MP, Hennenlotter J, Vogel UH, Krueger SA,Kuehs U, Schlemmer HP, Stenzl A, Schwentner C. “Topographical sensitivity andspecificity of endorectal coil magnetic resonance imaging for prostate cancerdetection.” Urol Int, 84(4):388-394, 2010.
  3. Reis LO, Zani EL, Freitas LL, Denardi F, Billis A. Higher prostate weight is inversely associated with Gleason score upgrading in radical prostatectomy specimens. Adv Urol. 2013;2013:710421. doi: 10.1155/2013/710421.
  4. Bostwick DG, “Pathological Implications of Prostate Biopsy” in “Prostate Cancer Diagnosis”. 2012; 189-225. DOI:10.1007/978-1-62703-188-2_16.
  5. Winters BR, Wright JL, Holt SK, Lin DW, Ellis WJ, Dalkin BL, Schade GR. Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-based Analysis. Urology. 2016 Oct;96:148-155. doi: 10.1016/j.urology.2016.04.058.
  6. DEMİRELHC, AKDEMİRAÖ, ÖZTEKİN ÇV, GÖKKAYA CS, ÇETİNKAYA M, MEMİŞ A. Ortadoğu Medical Journal. 2012;4(2):49-52.
A10. Ugurlu O, Yaris M, Oztekin CV, Kosan TM, Adsan O, Cetinkaya M, “Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: A prospective randomized controlled trial” Urol Int, 84:185-90, 2010. DOI:10.1159/000277596
  1. Sfanos KS, De Marzo AM. “Prostate cancer and inflammation: the evidence.” Histopathology, 60(1):199-215, 2012.
  2. Akduman B, Akduman D, Tokgöz H, Erol B, Türker T, Ayoğlu F, Mungan NA. “Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms.” Urology, 78(2):250-255, 2011.
  3. Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Brüggemann H, Nelson WG, De MarzoAM, Yegnasubramanian S, Sfanos KS. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate. 2013 Jun;73(9):1007-15. doi: 10.1002/pros.22648.
  4. Yang L, Zhu Y, Tang Z, Chen Y, Gao L, Liu L, Han P, Li X, Wei Q. Antibiotics may not decrease prostate-specific antigen levels or prevent unnecessary prostate biopsy in patients with moderately increased prostate-specific antigen levels: A meta-analysis. Urol Oncol. 2015 May;33(5):201.e17-24. doi: 10.1016/j.urolonc.2015.02.001.
  5. Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA. SIGIRR/TIR8, an importantregulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemicalrecurrence after prostatectomy in low-grade prostate carcinomas. Hum Pathol. 2015Nov;46(11):1744-51. doi: 10.1016/j.humpath.2015.07.015.
  6. Jones, Kia J., "The Contribution of Inflammatory Cells to the Progression of Prostate Cancer" (2016). Electronic Theses & Dissertations Collection for Atlanta University & Clark Atlanta University. 26.
  7. Staibano S. “Molecular Determinants of Cancer-Related Inflammation” in “Prostate cancer: Shifting from morphology to biology”, 2013;45-56. DOI:10.1007/978-94-007-7149-9_2
  8.  Yu Fan, Guo D,Wei Q, Tang Z, Cao DH, Yang Lu, Liu LR, Liu ZH, Li X, Xue WB, Lei JH. Antibiotics has incapability of reducing unnecessary prostate biopsies: a meta-analysis involving 2,035 patients. Int J Clin Exp Med. 2016;9(2):4658-73.
A11. Akdemir AO, Ozden C, Öztekin ÇV, Aktas BK, Cetinkaya M, Memis A, Doluoglu OG, “Stage-by-Stage Effects of Surgical Margin Status on Biochemical Failure after Radical Prostatectomy in Patients with Clinically Localized Prostate Cancer”, Urol Int, 86:156-160, 2011.     DOI:10.1159/000322840
  1. Huri E, Aydoğmuş Y, Doluoğlu ÖG, Dadalı M, Karakan T, Emir L, Germiyanoğlu C. Effect of positive surgical margins on biochemical failure, biochemical recurrence-free survival, and overall survival after radical prostatectomy: Median long-term results. Kaohsiung J Med Sci, 2014.
  2.  Ozden C, Aktas BK, Bulut S, Erbay G, Tagci S, Gokkaya CS, Baykam MM, Memis A.  Effect of age on biochemical recurrence after radical prostatectomy. Kaohsiung J  Med Sci. 2017 Feb;33(2):91-95. doi: 10.1016/j.kjms.2016.11.002.
A12. Akdemir AO, Demirturk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Cetinkaya M, Gur S, Hellstrom JG, “Imatinib Mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue”, Urology, 78:968.e1-968.e6, 2011.    DOI:10.1016/j.urology.2011.06.033
  1. Nina A. Maihöfer, Said Suleiman, Daniela Dreymüller, Paul W. Manley, Rolf Rossaint, Stefan Uhlig, Christian Martin† and Annette D. Rieg† Imatinib relaxes the pulmonary venous bed of guinea pigs. Respiratory Research 2017, 18:32,  DOI: 10.1186/s12931-017-0514-0
  2. Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ. Imatinibattenuates monocrotaline pulmonary hypertension and has potent vasodilatoractivity in pulmonary and systemic vascular beds in the rat. Am J Physiol HeartCirc Physiol. 2013 Nov 1;305(9):H1288-96. doi: 10.1152/ajpheart.00329.2013.
  3. Gur S, Sikka SC, Abdel-Mageed AB, Abd Elmageed ZY, Rezk B, Pankey E, Kadowitz  PJ, Hellstrom WJ. Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new  RTK targets. Urology. 2013 Sep;82(3):745.e11-6. doi: 10.1016/j.urology.2013.04.030.
  4. Pankey EA, Lasker GF, Gur S, Hellstrom WJ, Kadowitz PJ. Analysis of erectile responses to imatinib in the rat. Urology. 2013 Jul;82(1):253.e17-24. doi: 10.1016/j.urology.2013.04.009.
  5. Gur S, Sikka SC. The characterization, current medications, and promising therapeutics targets for premature ejaculation. Andrology. 2015 May;3(3):424-42.  doi: 10.1111/andr.12032.
A16. Öztekin ÇV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, Hellstrom WJ, “Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5-Alpha Reductase Inhibitor Therapy”, J Sex Med, 9(7):1773-1781, 2012.  DOI:10.1111/j.1743-6109.2012.02759.x
  1. Un O, Yilmaz D, Bayatli N, Kaya E, Gur S. L-arginine and tetrahydrobiopterin,  but not sodium nitrite partially restored erectile dysfunction in aged rats. Aging Male. 2014 Dec;17(4):248-55. doi: 10.3109/13685538.2014.921150.
  2. Traish, A.M. “The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being” Curr Sex Health Rep (2015) 7: 210. doi:10.1007/s11930-015-0061-y
  3. Traish AM, Mulgaonkar A, Giordano N.   The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression.   Korean J Urol. 2014 Jun;55(6):367-379.   https://doi.org/10.4111/kju.2014.55.6.367
  4. Gur S, Sikka SC. The characterization, current medications, and promising therapeutics targets for premature ejaculation. Andrology. 2015 May;3(3):424-42. doi: 10.1111/andr.12032. Review. PubMed PMID: 25951512.
  5. Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ. Imatinibattenuates monocrotaline pulmonary hypertension and has potent vasodilatoractivity in pulmonary and systemic vascular beds in the rat. Am J Physiol HeartCirc Physiol. 2013 Nov 1;305(9):H1288-96. doi: 10.1152/ajpheart.00329.2013.
  6. Irwig MS. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry. 2012 Sep;73(9):1220-3. doi: 10.4088/JCP.12m07887.
  7. Traish AM. 5α-reductases in human physiology: an unfolding story. Endocr Pract. 2012 Nov-Dec;18(6):965-75. doi: 10.4158/12108.RA.
  8. Zhang MG, Wang XJ, Shen ZJ, Gao PJ. Long-term oral administration of 5α-reductase inhibitor attenuates erectile function by inhibiting autophagy and promoting apoptosis of smooth muscle cells in corpus cavernosum of aged rats. Urology. 2013 Sep;82(3):743.e9 -15. doi: 10.1016/j.urology.2013.02.045.
  9. Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? Rev Endocr Metab Disord. 2015 Sep;16(3):177-98. doi: 10.1007/s11154-015-9319-y.
  10. Irwig MS. Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men. Sex Med Rev. 2014 Jan;2(1):24-35. doi: 10.1002/smrj.19.
  11. Irwig MS. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):248-53. doi: 10.1097/MED.0000000000000158.
  12. Traish AM, Haider KS, Doros G, Haider A. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Horm Mol Biol Clin Investig. 2015 Sep;23(3):85-96. doi: 10.1515/hmbci-2015-0015.
  13. Trost L, Saitz TR, Hellstrom WJ. Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review. Sex Med Rev. 2013 May;1(1):24-41. doi: 10.1002/smrj.3.
  14. Liu L, Zhao S, Li F, Li E, Kang R, Luo L, Luo J, Wan S, Zhao Z. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Reviewof Randomized Controlled Trials. J Sex Med. 2016 Sep;13(9):1297-310. doi: 10.1016/j.jsxm.2016.07.006.
  15. Gupta K, Yezdani M, Sotelo T, Aragon-Ching JB. A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2015;24(8):1059-73. doi: 10.1517/13543784.2015.1048333.
  16. Arias-Santiago S, Camacho-Martínez FM. Adverse Effects of 5-Alpha ReductaseInhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006.
  17. Xie, D., Chughtai, B., Elterman, D.S. et al. Curr Bladder Dysfunct Rep (2013) 8: 229. doi:10.1007/s11884-013-0187-6
A15. Doluoglu OG, Gokkaya CS, Aktas BK, Öztekin ÇV, Bulut S, Memis A, Cetinkaya M, “Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P.”, Int Urol Nephrol, 44(4):1085-1090, 2012. DOI:10.1007/s11255-012-0127-y
  1. Leyh  H , Necknig U.  Transurethrale Resektion der Prostata. Der Urologe. May 2014, Volume 53, Issue 5, pp 699-705
  2. Qian X, Kong X, Qian Y, et al. Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate. International Journal of Clinical and Experimental Medicine. 2015;8(7):11268-11275.
  3. Tao, Huang, Jiang, Yu Yong, Jun, Qi, Ding, Xu, Jian, Duan Liu, Jie, Ding, & Ping, Zhu Yu. (2016). Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate. International braz j urol, 42(2), 302-311. DOI: 10.1590/S1677-5538.IBJU.2014.0500
A18. Gökkaya CS, Öztekin ÇV, Özden C, Öztürk E, Aktaş BK, Memiş A, “Insulin resistance impairs response to doxazosin therapy in men with benign prostatic hyperplasia”, Turk J Med Sci, 43(1):1-5, 2013. DOI: 10.3906/sag-1203-90
  1. Umul M, Altay AM, Bademkıran F, Turna B, Semerci MB, Apaydın E, Çıkılı N. The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity. Turk J Med Sci 2014; 44(4): 681-686.
  2. Altın S, Ozan T, İlhan S, İlhan N, Onur R. Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study. Turkish Journal of Urology. 2015;41(3):125-131. doi:10.5152/tud.2015.89656
A20. Gökkaya CS,Özden C, Aktaş BK,Demirel HC, Güzel Ö, Karabakan M, Erkmen AE, Öztekin ÇV, Memiş A, “The Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms in Females”, Turk J Med Sci, 43(3):400-404, 2013. DOI: 10.3906/sag-1206-66 
  1. Bunn, F., Kirby, M., Pinkney, E., Cardozo, L., Chapple, C., Chester, K., Cruz, F., Haab, F., Kelleher, C., Milsom, I., Sievart, K. D., Tubaro, A. and Wagg, A. (2015), Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract, 69: 199–217. doi:10.1111/ijcp.12518
A21. Öztekin ÇV, Gür S, Abdulkadir NA, Kartal M, Karabakan M, Akdemir AÖ, Gökkaya CS, Çetinkaya M, “Analysis of pomegranate juice components in rat corpora cavernosal relaxation”, Int J Impot Res, 2013.DOI:10.1038/ijir.2013.33 [1 Ağustos 2013 tarihinde online olarak yayınlanmıştır.]
  1. E Onal, D Yilmaz, E Kaya, T Bastaskın, N Bayatlı and S Gur, Pomegranate juice causes a partial improvement through lowering oxidative stress for erectile dysfunction in streptozotocin-diabetic rat, International Journal of Impotence Research (2016) 28, 234–240; doi:10.1038/ijir.2016.34
  2. Gur, S., Rezk, B. M., Abd Elmageed, Z. Y., Kadowitz, P. J., Sikka, S. C. and Hellstrom, W. J. G. (2016), Characterisation of pomegranate juice effects on human corpus cavernosum. Andrologia. doi:10.1111/and.12712
  3. Eyad M. MALLAH, Walid S.A. RAYYAN, Wael A.A. DAYYIH, Feras D. ELHAJJI, Kenza A. MANSOUR, Ibrahim S. AL-MAJALI, Tawfiq A. ARAFAT, ”Dose-Dependent Synergistic effect of Pomegranate Juice on the Bioavailability of Sildenafil in Rats by Using HPLC Method” Lat. Am. J. Pharm. 35 (6): 1277-84 (2016)
A23. Ercan M, Akbulut ED, Abuşoğlu S, Yılmaz FM, Oğuz EF, Topçuoğlu C, Öztekin ÇV, Boğdaycıoğlu N. “Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to urinalysis.” Clin Biochem. 2015 May 27. pii: S0009-9120(15)00207-6. DOI:10.1016/j.clinbiochem.2015.05.016
  1. Ekşioğlu MK1, Madenci ÖÇ1, Yücel N1, Elçi A2, Turhan B2, Orhan G2, Orçun A1.The effectiveness of BD Vacutainer® Plus Urinalysis Preservative Tubes in preservation of urine for chemical strip analysis and particle counting. Biochem Med (Zagreb). 2016;26(2):224-32. doi: 10.11613/BM.2016.024.
  2. Joris R. Delanghe, ⁎, Marijn M. Speeckaert, Preanalytics in urinalysis, Clinical Biochemistry 49 (2016) 1346–1350. http://dx.doi.org/10.1016/j.clinbiochem.2016.10.016 0
D16.Özer Güzel, Çetin Volkan Öztekin, Alp Özgür Akdemir, Mehmet Karabakan, Mesut Çetinkaya Giant Fecaloma Leading to Bilateral Ureterohydronephrosis Erciyes Med J 2015; 37(3): 110-2 • DOI: 10.5152/etd.2015.7161
  1. Kim, J., Yoon, H. and Eom, K. (2017), IMAGING DIAGNOSIS — RADIOGRAPHY, ULTRASONOGRAPHY, AND COMPUTED TOMOGRAPHY OF A GIANT FECALOMA CAUSING STERCORAL PERFORATION OF THE COLON IN A DOG WITH A PROSTATIC ABSCESS. Vet Radiol Ultrasound. doi:10.1111/vru.12476

Doğum Tarihi: 29/01/1973
Konuştuğu Diller : İngilizce

Doç. Dr.
Çetin Volkan ÖZTEKİN

Doğum Tarihi: 29/01/1973

Konuştuğu Diller : İngilizce

volkan.oztekin@med.neu.edu.tr

  • Ana Bilim Dalı: Üroloji
  • 2014 TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Doçentlik
  • 2002 Üroloji TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Yardımcı Doçentlik
  • 2002 TC SB Ankara Numune Eğitim ve Araştırma Hastanesi
    Doktora - Uzmanlık
  • Hacettepe Üniversitesi Tıp Fakültesi
    Yüksek Lisans
  • 1987-1990 Lise TED Ankara Koleji
  • 1974-1984 Orta TED Ankara Koleji
  • 1974-1984 İlk TED Ankara Koleji
  • Türk Üroloji Derneği
  • Ürolojik Cerrahi Derneği
  • Ankara Ürologlar Derneği
  • Endoüroloji Derneği
  • Üroonkoloji Derneği
ESERLER A. Uluslararası hakemli dergilerde yayımlanan makaleler :
  1. Aydos MM, Memiş A, Yakupoğlu YK, Özdal OL, Öztekin V, “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”, BJU Int, 88:382-384, 2001.
  2. Ozturk B, Cetinkaya M, Gur S, Ugurlu Ö, Öztekin V, Akı FT, “The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder”, Urol Res, 30:178-184, 2002. DOI:10.1007/s00240-002-0247-4
  3. Ozturk B, Cetinkaya M, Öztekin V, Inal G, Adsan O, Ugurlu O, Ozden C, “Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms”, Urol Int, 71:22-25, 2003. DOI:10.1159/000071088
  4. Öztekin ÇV, Ozturk B, Tas M, Ugurlu O, Cetinkaya M, “How do patients with familial benign prostatic hyperplasia differ clinically from those with sporadic benign prostatic hyperplasia?”, Urol Int, 76:332-334, 2006. DOI:10.1159/000092057
  5. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Öztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, Urology, 70(1):55-59, 2007. DOI:10.1016/j.urology. 2007.03.015
  6. Kosan M, Gonulalan U, Ugurlu O, Öztekin V, Akdemir O, Adsan O, “Testicular microlithiasis in patients with scrotal symptoms and its relationship to testicular tumors”, Urology, 70(6):1184-1186, 2007.  DOI:10.1016/j.urology.2007.07.049
  7.  Inal GH, Öztekin ÇV, Ugurlu O, Kosan M, Akdemir O, Cetinkaya M, “Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies”, Prostate Cancer Prostatic Dis, 11(3):270-273, 2008. DOI:10.1038/pcan.2008.34
  8. Ugurlu O, Cetinkaya M, Ozden C,Öztekin ÇV, Akdemir AO, Memis A, Yaris M, “An abnormal digital rectal examination is an independent predictor of high radical prostatectomy Gleason’s score (≥7) in patients with clinically localized prostate cancer”, Turk J Med Sci, 39(5):755-760, 2009. DOI:10.3906/sag-0807-1
  9. Ozden C, Öztekin ÇV, Ugurlu O, Gokkaya S, Yaris M, Memis A, “Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy”, Urol Int, 83:146-150, 2009. DOI:10.1159/000230014
  10. Ugurlu O, Yaris M, Öztekin ÇV, Kosan TM, Adsan O, Cetinkaya M, “Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: A prospective randomized controlled trial” Urol Int, 84:185-190, 2010. DOI:10.1159/000277596
  11. Akdemir AO, Ozden C, Öztekin ÇV, Aktas BK, Cetinkaya M, Memis A, Doluoglu OG, “Stage-by-Stage Effects of Surgical Margin Status on Biochemical Failure after Radical Prostatectomy in Patients with Clinically Localized Prostate Cancer”, Urol Int, 86:156-160, 2011.     DOI:10.1159/000322840
  12. Akdemir AO, Demirturk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Cetinkaya M, Gur S, Hellstrom JG, “Imatinib Mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue”, Urology, 78:968.e1-968.e6, 2011.    DOI:10.1016/j.urology.2011.06.033
  13. Memis A, Ugurlu O, Ozden C, Öztekin ÇV, Aktas BK, Akdemir AO, “The correlation among the percentage of positive biopsy cores from the dominant side of prostate, adverse pathology, and biochemical failure after radical prostatectomy”, Kaohsiung J Med Sci, 27:307-313, 2011. DOI:10.1016/j.kjms.2011.03.009
  14. Akdemir AO, Öztekin ÇV, Doluoglu OG, Karabakan M, Ugurlu O, Cetinkaya M. “The effects of transurethral resection of the prostate on morbidity and mortality in patients with nondialysis-requiring renal insufficiency.”, Ther Adv Urol, 4(2):51-56, 2012.   DOI:10.1177/1756287211435088
  15. Doluoglu OG, Gokkaya CS, Aktas BK, Öztekin ÇV, Bulut S, Memis A, Cetinkaya M, “Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P.”, Int Urol Nephrol, 44(4):1085-1090, 2012. DOI:10.1007/s11255-012-0127-y
  16. Öztekin ÇV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, Hellstrom WJ, “Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5-Alpha Reductase Inhibitor Therapy”, J Sex Med, 9(7):1773-1781, 2012.  DOI:10.1111/j.1743-6109.2012.02759.x
  17.  Postacı A, Aytaç İ, Öztekin ÇV, Dikmen B, “Acute unilateral parotid gland swelling after lateral decubitus position under general anesthesia”, Saudi J Anaesth, 6(3):307-309, 2012.DOI: 10.4103/1658-354X.101227
  18. Gökkaya CS, Öztekin ÇV, Özden C, Öztürk E, Aktaş BK, Memiş A, “Insulin resistance impairs response to doxazosin therapy in men with benign prostatic hyperplasia”, Turk J Med Sci, 43(1):1-5, 2013. DOI: 10.3906/sag-1203-90
  19. Öztekin ÇV, Gökkaya CS, Çiçekçioğlu H, Uçar Ö, Çetin M, Öztürk E, Memiş A, “Acute myocardial infarction without cardiogenic shock does not affect serum prostate spesific antigen levels: A case control study”, Int J Cardiol, 166(1):272-273, 2013. DOI: 10.1016/j.ijcard.2012.09.236
  20. Gökkaya CS,Özden C, Aktaş BK,Demirel HC, Güzel Ö, Karabakan M, Erkmen AE, Öztekin ÇV, Memiş A, “The Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms in Females”, Turk J Med Sci, 43(3):400-404, 2013. DOI: 10.3906/sag-1206-66 
  21. Öztekin ÇV, Gür S, Abdulkadir NA, Kartal M, Karabakan M, Akdemir AÖ, Gökkaya CS, Çetinkaya M, “Analysis of pomegranate juice components in rat corpora cavernosal relaxation”, Int J Impot Res, 2013.DOI:10.1038/ijir.2013.33 [1 Ağustos 2013 tarihinde online olarak yayınlanmıştır.]
  22. Doluoğlu ÖG, Saricaoğlu MS, Öztekin ÇV, Karakurt A, Akdemir AÖ, Koc E, “Cortical Blindness due to Bilateral Occipital Infarcts in a Renal Failure Patient with Prostate Cancer: A Rare Complication of Hemodialysis.”, Case Rep Med, 2013. DOI: 10.1155/2013/539761 [9 Ocak 2013 tarihinde online olarak yayınlanmıştır.]
  23. Ercan M, Akbulut ED, Abuşoğlu S, Yılmaz FM, Oğuz EF, Topçuoğlu C, Öztekin ÇV, Boğdaycıoğlu N. “Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to urinalysis.” Clin Biochem. 2015 May 27. pii: S0009-9120(15)00207-6. DOI:10.1016/j.clinbiochem.2015.05.016
B.Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler:
  1. Aydos M, Memiş A, Öztürk B, Ulusoy E, Öztekin V, Çetinkaya M, “Our end-to-end urethroplasty results for traumatic posterior urethral strictures”, 14th Congress of the European Association of Urology, Eur Urol, 35(suppl2):2, Stockholm, Sweden, Nisan, 1999.
  2. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Oztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, 21th Congress of the European Association of Urology, Eur Urol Suppl, 5(2):667, Paris, France, Nisan, 2006.
  3. Ugurlu O, Yaris M, OztekinCV, Kosan TM, Adsan O, Cetinkaya M, “Impact of antibacterial therapy on biopsy decision in the presence of prostatic inflammation in patients with prostate specific antigen levels between 2.5 and 10 ng/ml: A prospective randomized controlled trial”, 23rd Congress of the European Association of Urology, Eur Urol Suppl, 7(3):275, P17, Milan, Italy, Mart, 2008.
  4. Cetinkaya M, Oztekin CV, Ugurlu O, Yaris M, Lokman U, Adsan O, “The Relationship between sonographically measured prostatic indentation, prostatic urethral length and bladder-urethral angle and urodynamic bladder outlet obstruction parameters”, 24th Congress of the European Association of Urology, Eur Urol Suppl, 8(4):459, P29, Stockholm, Sweden, Mart, 2009.
  5. Doluoglu OG, Gokkaya CS, Aktas BK, Oztekin V, Bulut S, Memis A, Cetinkaya M, “Impact of pathologically proven prostatic inflamation on re-operation rates due to urethral or bladder neck strictures after transurethral resection of the prostate”, 26th Congress of the European Association of Urology, Eur Urol Suppl, 10(2):119, Vienna, Austria, Mart, 2011.
  6. Akdemir AO, Demirturk K, Karabakan M, Oztekin CV, Abdulkadir NA, Cetinkaya M, Gur S, "Imatinib Mesylate (Gleevec) as a protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue" AUA Annual Meting2011, J Urol 185(4S):630, Washington DC, ABD, Mayıs 2011
  7. Gökkaya C.S, Öztekin C.V, Özden C, Öztürk E, Aktaş B.K, Memiş A, "Isolated insulin resistance impairs response to doxasosin therapy in men with lower urinary tract symptoms due to BPH", 26th Congress of the European Association of Urology, Eur Urol Suppl, 10(2):120, Viyana, Avusturya, Mart 2011
  8. Gökkaya CS, Öztekin ÇV, Demirdal Ö, Gökkaya NK, Özden C, Uçan H, Memiş A, "Complete spinal cord lesions decrease prostate size without changing serum PSA levels. Are free PSA and PSA derivatives affected?", AUA Annual Meting, 2011, J Urol, 185(4S):697, Washington DC, ABD, Mayıs 2011
  9. Öztekin ÇV, Gökkaya CS, Çiçekçioğlu H, Uçar Ö, Çetin M, Öztürk E, Şahin M, Memiş A, "Acute Myocardial Infarction Without Cardiogenic Shock Does Not Affect Serum Prostate Specific Antigen Levels: A Case-Control Study.", 31st Congress of the SIU Urology, 78(Supp3A):327, Berlin, Almanya, Ekim 2011
  10. Gür S, şerefoglu EC, Öztekin ÇV, Lokman U, Un Ö, Gökkaya CS, Kadowitz PJ, Hellstrom WJG, “Silodosin (Kmd-3213) Is A Long-Acting Α-1a Adrenoceptor Antagonist With Activity In The Human Corpus Cavernosum.”, J Urol, 187(4): e331. (AUA Annual Meeting, Atlanta GA, ABD, 19-23 Mayıs 2012). DOI: http://dx.doi.org/10.1016/j.juro.2012.02.899
  11. Karabakan M, Akdemir S, Akdemir AÖ, Öztekin ÇV, Güzel Ö, Gökkaya CS, Çetinkaya M, “The Effect Of Ejaculation Frequency On Serum Prostate Spesific Antigen Level”, J Urol, 191(4):e 862.  (AUA Annual Meeting, Orlando FL, ABD, DOI: http://dx.doi.org/10.1016/j.juro.2014.02.2348
C. Yazılan uluslararası kitaplar veya kitaplarda bölümler : D. Ulusal hakemli dergilerde yayınlanan makaleler:
  1. Aydos M, Oral S, Öztürk B, Öztekin V, Akdemir Ö, Çetinkaya M, “Okul çağı çocuklardaki adolesan varikoselini tarama amaçlı yaptığımız saha çalışması sonuçlarımız”, Türk Üroloji Dergisi, 25(4), 430-435, 1999.
  2. Öztürk B, İnal G, Gökkaya S, Öztekin V, Memiş A, Çetinkaya M, “Erektil Disfonksiyonu Olan 127 Hastanın Nokturnal Penil Tümesans ve Rigidite Sonuçlarının Analizi”, Üroloji Bülteni, 12: 103-106, 2001.
  3. Öztekin ÇV, Akdemir AÖ, Doluoğlu ÖG, Uğurlu Ö, Sungur M, Çetinkaya M,  “Lokalize renal hücreli kanserlerde (pT≤2) renal kapsül infiltrasyonunun prognoz üzerine etkileri’’, Türk Üroloji Dergisi, 36(4):328-332, 2010. DOI:10.5152/tud.2010.039
  4. Doluoğlu ÖG, Öztekin ÇV, Uğurlu Ö. “Bosniak 3-4 renal kistlerde biyopsinin gereklilik ve sınırlamaları”, Üroonkoloji Bülteni, 3:40-42, 2010.
  5. Koşan M, Öztekin ÇV, “Olgu Sunumu: Mesane kanseri”, Üroonkoloji Bülteni, 1: 75-78, 2010.
  6. Uğurlu Ö, Öztekin V, Koşan M, Doluoğlu ÖG, Adsan Ö, Çetinkaya M, “Radikal sistoprostatektomi serimizde mesane tümörü ile prostat adenokarsinoma birlikteliğinin sağkalıma etkisi” J Clin Anal Med, 1(2): 1-4, 2010. DOI: 10.4328/JCAM.10.2.11
  7. Öztekin ÇV, Erşahin V. “İdame BCG kime uygulanmalı, nasıl uygulanmalı?”, Üroonkoloji Bülteni, 1:21-22, 2011.
  8. Mesut Çetinkaya, Öztekin ÇV. “Benign prostat hiperplazisi ve heredite”. Üroonkoloji bülteni 4:20-22, 2011.
  9. Gokkaya CS, Öztekin CV, Doluoglu OG, Guzel O, Ersahin V, Ozden C, Memis A. Validation of Turkish version of Bristol female lower urinary tract symptom index. J Clin Anal Med, 3(4):415-418, 2012. DOI: 10.4328/JCAM.814
  10. Demirel HC, Gökkaya CS, Özden Ö, Aktaş BK, Bulut S, Memiş A, Öztekin ÇV, “The risk factors for acute urinary retention in patients with benign prostatic hyperplasia”, Türk Üroloji Dergisi, 38(2):65-69, 2012.DOI:10.5152/tud.2012.016.
  11. Akdemir AÖ, Lokman U, Öztekin ÇV, Sungur M, Adsan Ö. “Transverse Testicular Ectopia In An Adult Male; A Rare Form of Persistent Mullerian Duct Syndrome: A Case Report.”, J Clin Anal Med, 4(2):143-145,2013, DOI: 10.4328/JCAM.627
  12. Çetinkaya M, Öztekin ÇV, “Prostat kanserinde Chemoprevention”, Üroloji Bülteni, [Yayına kabul tarihi: 19 Ocak 2012]
  13. Gökkaya CS, Öztekin ÇV, Demirdal Ö, Gökkaya NK, Özden C, Uçan H, Memiş A. “Prostate-Specific Antigen and its Derivatives in Spinal Cord Injured Patients; A Case-Control Study” J Clin Anal Med, 4(6):491-494,2013, DOI: 10.4328/JCAM.1108
  14. Doluoğlu ÖG, Öztekin ÇV, Karabakan M, Akdemir AÖ, Çetinkaya M. The importance of prostate volume in prostate needle biopsy. Turkish journal of urology. 2013;39(2):74-77. doi:10.5152/tud.2013.019.
  15. Özer G, Öztekin ÇV, Akdemir AÖ, Gökkaya CS. “Sünnet operasyonunda kanama kontrolü için radyofrekans kullanımının bipolar elektrokoterizasyon ve sütür ile bağlama yöntemleri ile karşılaştırılması”, J Turgut Özal Med Cent, 20(2):129-132,2013 [Çalışma basıma kabul edildiğinde İnönü Üniversitesi Tıp Fakültesi Dergisi olan derginin adı Journal of Turgut Özal Medical Center olarak değiştirilmiştir].
  16. Güzel Ö, Öztekin ÇV, Sungur, M, Uğurlu Ö, Doluoğlu ÖG, Yılmaz N, Çetinkaya M. Benign Prostat Hiperplazisinde Tolterodin ve Tamsulosin Kombinasyonunun Semptomlar ve Mesane Çıkım Obstrüksiyonu Üzerine Etkisi. İnönü Tıp Fakültesi Dergisi, 20(1):12-18
  17. Karabakan M, AkdemirAÖ, Öztekin ÇV , Özge Han , Serkan Akdemir, “İyi Diferansiye Skrotal Liposarkom”, İnönü Üniversitesi Sağlık Bilimleri Dergisi 2014; 3 (1): 43-44
  18. Karabakan M, Akdemir S, Akdemir AÖ, Öztekin ÇV , Güzel Ö, Gökkaya CS, Çetinkaya M. “The Effect of Ejaculation Frequency on Serum ProstateSpecific Antigen Level.” Journal of Academic research in medicine, 5:56-59,2015, DOI: 10.5152/jarem.2015.685
  19. Özer Güzel, Öztekin ÇV, Alp Özgür Akdemir, Mehmet Karabakan, Mesut Çetinkaya Giant Fecaloma Leading to Bilateral Ureterohydronephrosis Erciyes Med J 2015; 37(3): 110-2 • DOI: 10.5152/etd.2015.7161
E. Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler:  
  1. Aydos, M., Memiş, A., Öztürk, B., Ulusoy, E., Öztekin, V., Çetinkaya, M, "Travmatik posterior üretra darlıklarında end-to-end üretroplasti sonuçlarımız", 15. Ulusal Üroloji Kongresi konferansı dahilinde "15. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:66, Antalya, Türkiye, Ekim1998
  2. Öztürk, B., İnal, G., Gökkaya, S., Öztekin, V., Memiş, A., Çetinkaya, M, "Erektil Disfonksiyonu olan 127 hastanın Nokturnal Penil Tümesans ve Rigidite sonuçlarının analizi", 16. Ulusal Üroloji Kongresi konferansı dahilinde "16. Ulusal Üroloji Kongresi" bildiri kitapçığı, Sunum No: p-276, İzmir, Türkiye, Ekim 2000
  3. Adsan, Ö., Çetinkaya, M., Özden, C., Akı, T., Öztürk, B., Öztekin, V, "BPH nedeniyle opere edilen yüksek PSA’ lı hastaların erken takip sonuçları", 16. Ulusal Üroloji Kongresi konferansı dahilinde "16. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:166, İzmir, Türkiye, Ekim 2000
  4. Öztürk B, Gökkaya S, Akar E, Öztekin V, Koparal S, Çetinkaya M, "Tek olarak veya papaverin ile birlikte kullanılan sildenafilin erektil disfonksiyonu olan hastaların penil renkli doppler ultrason parametrelerine etkisi", 17. Ulusal Üroloji Kongresi konferansı dahilinde "17. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:237, Antalya, Türkiye, Ekim 2002
  5. Öztürk B, Çetinkaya M, Gür S, Uğurlu Ö, Öztekin V, İnal G, "Parsiyel çıkım obstrüksiyonun diyabetik ve diayabetik olmayan rat detrüsörü relaksasyonu üzerine erken etkileri", 17. Ulusal Üroloji Kongresi konferansı dahilinde "17. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:35, Antalya, Türkiye, Ekim 2002
  6. Uğurlu Ö, Gönülalan U, Adsan Ö, Koşan M, Öztekin V, Çetinkaya M, "BPH Ve Üç Santimetreden Küçük Tek Odaklı Yüzeyel Mesane Tümörlü Hastaların Aynı Seansda Transüretral Rezeksiyonla Tedavisinin Rekürrens Ve Progresyona Etkisi", 19. Ulusal Üroloji Kongresi konferansı dahilinde "19. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:178-179, Antalya, Türkiye, Haziran 2006
  7. Koşan M, Yariş M, Uğurlu Ö, Öztekin V, Adsan Ö, Çetinkaya M, "Lokalize Prostate Kanseri Nedeniyle Radikal Retropubik Prostatektomi Uygulanan Hastalarda Preoperatif PSA Parametrelerinin Progresyonla İlişkisi", 19. Ulusal Üroloji Kongresi konferansı dahilinde "19. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:346, Antalya, Türkiye, Haziran 2006
  8. Koşan M, Gönülalan U, Uğurlu Ö, Öztekin V, Akdemir Ö, Adsan Ö, "Skrotal Semptom İle Başvuran Hastalarda Testiküler Mikrolitiyazis Oranı Ve Testiküler Tümörle İlişkisi", 17. Ulusal Kanser Kongresi konferansı dahilinde "17. Ulusal Kanser Kongresi" bildiri kitapçığı, sayfa:59, Antalya, Türkiye, Nisan 2007
  9. Uğurlu Ö, Öztekin V, Koşan M, Doluoğlu Ö, Adsan Ö, Çetinkaya M, "Radikal Sistoprostatektomi Serimizde Mesane Tümörü İle Prostat Adeno Ca Birlikteliğinin Sağkalıma Etkisi", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:106, Ankara, Türkiye, Kasım 2007
  10. İnal G, Öztekin V, Uğurlu Ö, Koşan M, Akdemir AÖ, Çetinkaya M, "Prostat Biyopsilerinde Onaltı G İğne Kullanımının Kanser Yakalama Oranı Ve Örnek Doku Kalitesine Etkileri", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:49, Ankara, Türkiye, Kasım 2007
  11. Koşan M, Yariş M, Öztekin ÇV, Uğurlu Ö, Akdemir Ö, Çetinkaya M, "İleri Evre Prostat Kanseri Tedavisinde Steroidal Ve Non-Steroidal Antiandrojenlerin Serum Lipid Profiline Etkisi", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:91, Ankara, Türkiye, Kasım 2007
  12. Uğurlu Ö, Çetinkaya M, Özden C, Öztekin V, Akdemir Ö, Memiş A, Yariş M, "Klinik lokalize prostat kanserinde parmakla rektal muayene ve serbest/total PSA yüzdesi kullanılarak yüksek Gleason skoru öngörülebilir mi?", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:57, Ankara, Türkiye, Kasım 2007
  13. Akdemir Ö, Koşan M, Sungur M, Adsan Ö, Öztekin V, Çetinkaya M, "Lokalize Böbrek Tümörlerinde Tümörün Yerleşim Bölgesi İle Progresyonu Arasındaki İlişki", 8. Ankara Üroonkoloji Kursu konferansı dahilinde "8. Ankara Üroonkoloji Kursu" bildiri kitapçığı, sayfa:134, Ankara, Türkiye, Kasım 2007
  14. Çetinkaya M, Öztekin ÇV, Uğurlu Ö, Yariş M, Lokman U, Adsan Ö, "Transrektal ultrasonografi kullanılarak ölçülen prostatik indentasyon, prostatik üretra uzunluğu ve mesane-üretra açısı ile ürodinamik mesane çıkım obstrüksyonu parametrelerinin ilişkisi", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:474, Antalya, Türkiye, Kasım 2008
  15. Öztekin ÇV, Sungur M, Uğurlu Ö, Doluoğlu ÖG, Yılmaz N, Çetinkaya M, "Benign Prostat Hiperplazisine bağlı alt üriner sistem semptomlarının tedavisinde tolterodinin monoterapi ve tamsulosin ile kombine olarak kullanımının tamsulosin ile prospektif randomize olarak karşılaştırılması", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:144, Antalya, Türkiye, Kasım 2008
  16. Özden C, Öztekin ÇV, Uğurlu Ö, Gökkaya CS, Yariş M, Memiş A, “Radikal prostatektomi sonrası prostat biyopsisi gleason skor yükselmesi ile patolojik özellikler ve biyokimyasal başarısızlık arasındaki ilişki, 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:310, Antalya, Türkiye, Kasım 2008
  17. Ugurlu Ö, Yariş M, Öztekin ÇV, Koşan M, Adsan Ö, Çetinkaya M, "Prostat İnflamasyonu Varlığında Antibakteriyel ve Antiinflamatuar Tedavilerin Serum PSA Seviyelerine Etkisi: Prospektif Randomize Kontrollü Çalışma", 20. Ulusal Üroloji Kongresi konferansı dahilinde "20.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:90, Antalya, Türkiye, Kasım 2008
  18. Akdemir AO, Özden C, Öztekin CV, Aktaş BK, Çetinkaya M, Memiş A, "Klinik lokalize prostat kanserli hastalarda radikal retropubik prostatektomi sonrası cerrahi sınır pozitifliği ile biyokimyasal başarısızlık arasındaki ilişki", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:264-265, Ankara, Türkiye, Kasım 2009
  19. Öztekin ÇV, Akdemir AÖ, Uğurlu Ö, Kılınç R, Adsan Ö, Çetinkaya M, "Mesane kanseri olan hastalarda makroskopik hematüri varlığı ve ilk hematüri atağından sonra geçen sürenin prognostik faktörler ile ilişkileri", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:110, Ankara, Türkiye, Kasım 2009
  20. Akdemir AO, Özden C, Öztekin CV, Gökkaya CS, Çetinkaya M, Memiş A, "Preoperatif prostat biyopsisine göre radikal prostatektomi sonrası gleason skor yükselmesinin pozitif prostat biyopsi kor yüzdesi ile ilişkisi", 9.Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:262-263, Ankara, Türkiye, Kasım 2009
  21. Öztekin ÇV, Çetinkaya M, Akdemir AÖ, Uğurlu Ö, Baykal Y, Lokman U, "Benign Prostat Hiperplazisinde bağlı kalıcı üriner retansiyon gelişmesine etki eden faktörler", 9. Üroonkoloji Kongresi konferansı dahilinde "9. Üroonkoloji Kongresi" bildiri kitapçığı, sayfa:316, Ankara, Türkiye, Kasım 2009
  22. Öztekin ÇV, Uğurlu Ö, Sungur M, Akdemir AÖ, Doluoğlu ÖG, Çetinkaya M, "Retroperitoneal Laparoskopi Deneyimimiz: İlk 40 olgu", 8. Ulusal Endoüroloji Kongresi konferansı dahilinde "8. Ulusal Endoüroloji Kongresi" bildiri kitapçığı, sayfa:172, Antalya, Türkiye, Kasım 2009
  23. Akdemir AÖ, Demirtürk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Çetinkaya M, Gür S, "Bir Protein Tirozin Kinaz İnhibitörü Olan İmatinib Mesilat’ın (Gleevec) İzole İnsan Prostat Dokusu Üzerinde Düz Kas Gevşetici Etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:164-165, İstanbul, Türkiye, Ekim 2010
  24. Akdemir AÖ, Öztekin ÇV, Doluoğlu ÖG, Karabakan M, Uğurlu Ö, Çetinkaya M, "Hafif Serum Kreatinin Yüksekliği Olan (1.5-3 mg/dl) BPH’li Hastalarda TUR-P’nin Mortalite ve Morbiditeye Etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:32-33, İstanbul, Türkiye, Ekim 2010
  25.  Doluoğlu ÖG, Gökkaya CS, Aktaş BK, Öztekin ÇV, Bulut S, Memiş A, Çetinkaya M, "Transüretral prostat rezeksiyonu sonrası mesane boynu darlığı ve üretra darlığı gelişiminde prostat enflamasyonunun etkisi", 21.Ulusal Üroloji Kongresi konferansı dahilinde "21. Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:30, İstanbul, Türkiye, Ekim 2010.
  26. Gökkaya CS, Aktaş BK, Öztekin ÇV, Salar R, Özden C, Memiş A, "Prostat İğne Biyopsisi Erken Dönemde Prostat Hacmini Veya Alt Üriner Sistem Semptomlarını Değiştiriyor mu?", 22.Ulusal Üroloji Kongresi konferansı dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:308-309, Girne, KKTC, Mayıs 2012
  27. Gökkaya CS, Özden C, Aktaş BK, Demirel HC, Güzel Ö, Karabakan M, Erkmen MA, Öztekin ÇV, Memiş A, "Kadınlarda Metabolik Sendrom ile Alt Üriner Sistem Semptomları Arasındaki İlişki", 22.Ulusal Üroloji Kongresi konferansı dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:18-19, Girne, KKTC, Mayıs 2012
  28. Doluoğlu ÖG, Öztekin ÇV, Karabakan M, Akdemir AÖ, Çetinkaya M, “Prostat İğne Biyopsisinde Prostat Volümünün Önemi”, 22.Ulusal Üroloji Kongresi dahilinde "22.Ulusal Üroloji Kongresi" bildiri kitapçığı, sayfa:228, Girne, KKTC, Mayıs 2012
  29. Özer G, Öztekin ÇV, Akdemir AÖ, Gökkaya CS, 1.Ulusal Ürolojik Cerrahi Kongresi dahilinde “1.Ürolojik Cerrahi Kongresi” bildiri kitapçığındaki “Sünnet operasyonunda kanama kontrolü için radyofrekans kullanımının bipolar elektrokoterizasyon ve sütür ile bağlama yöntemleri ile karşılaştırılması”,  1. Ulusal Ürolojik Cerrahi Kongresi dahilinde 1.Ulusal Ürolojik Cerrahi Kongresi Bildiri Kitapçığı, sayfa:16, Antalya, Türkiye, Ekim 2012G. Atıflar
A1. Aydos MM, Memiş A, Yakupoğlu YK, Özdal OL, Öztekin V, “The use and efficacy of the American Urological Association Symptom Index in assessing the outcome of urethroplasty for post-traumatic complete posterior urethral strictures”, BJU Int, 88:382-384, 2001.
  1. Lumen N, Spiers S, De Backer S, Pieters R, Oosterlinck W. “Assessment of the short-term functional outcome after urethroplasty: a prospective analysis.” Int Braz J Urol, 37(6):712-718, 2011.
  2. Johnson EK, Latini JM. “The impact of urethroplasty on voiding symptoms and sexual function.” Urology, 78(1):198-201. 2011.
  3. Cooperberg MR, McAninch JW, Alsikafi NF, Elliott SP. “Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience.” J Urol, 178(5):2006-2010, 2007.
  4. Osterberg EC, Gaither TW, Awad MA, Alwaal A, Erickson BA, McAninch JW, Breyer  BN. Current Practice Patterns Among Members of the American Urological Association for Male Genitourinary Lichen Sclerosus. Urology. 2016 Jun;92:127-31. doi: 10.1016/j.urology.2016.02.033.
  5. DeLong J, Buckley J. Patient-reported outcomes combined with objective data toevaluate outcomes after urethral reconstruction. Urology. 2013 Feb;81(2):432-6. doi: 10.1016/j.urology.2012.10.046.
  6. Wessels SG, Heyns CF. Prospective evaluation of a new visual prostate symptom  score, the international prostate symptom score, and uroflowmetry in men with urethral stricture disease. Urology. 2014 Jan;83(1):220-4. doi: 10.1016/j.urology.2013.08.058
  7. Hosseini J, Tavakkoli Tabassi K. Surgical repair of posterior urethral defects: review of literature and presentation of experiences. Urol J. 2008 Fall;5(4):215-22.
  8. Goonesinghe SK, Hillary CJ, Nicholson TR, Osman NI, Chapple CR. Flexible cystourethroscopy in the follow-up of posturethroplasty patients and characterisation of recurrences. Eur Urol. 2015 Sep;68(3):523-9. doi: 10.1016/j.eururo.2015.04.013
  9. Osterberg EC, Schulster M, Blaivas JG, Maganty A, Lee DJ, Purohit RS. Urethroplasty Improves Overactive Bladder Symptoms in Men With Anterior Urethral  Strictures. Urology. 2016 Jul;93:208-12. doi: 10.1016/j.urology.2016.04.003
  10. Heyns CF. Follow-up strategies after urethral stricture treatment in Advanced male Urethral and Genital Reconstructive Surgeryby Brandes SB, Morey AF., 2013 413-415. DOI:10.1007/978-1-4614-7708-2_28
  11. Zhao CL, Gonzales CM. The Use of Patient-Reported Outcome Measures in Men with Urethral Stricture Disease in in Advanced male Urethral and Genital Reconstructive Surgeryby Brandes SB, Morey AF. 2013; 435-448. DOI: 10.1007/978-1-4614-7708-2_30
  12. Ali S, Shahnawaz, Shahzad I, Baloch MU. Delayed Single Stage Perineal Posterior Urethroplasty. J Coll Physicians Surg Pak. 2015 Jun;25(6):438-42. doi: 06.2015/JCPSP.438442.
  13. Odoemene CA, Okere P. One-stage Anastomotic Urethroplasty for Traumatic Urethral Strictures. January 2004-January 2013. Niger J Surg. 2015 Jul-Dec;21(2):124-9. doi: 10.4103/1117-6806.162574.
A2. Ozturk B, Cetinkaya M, Gur S, Ugurlu Ö, Oztekin V, Akı FT, “The early effects of partial outflow obstruction on contractile properties of diabetic and non-diabetic rat bladder”, Urological Research, 30:178-184, 2002. DOI:10.1007/s00240-002-0247-4
  1. Michel MC, Barendrecht MM. “Physiological and pathological regulation of the autonomic control of urinary bladder contractility.” Pharmacol Ther, 117(3):297-312, 2008.
  2. Gur S, Irat AM. “L-carnitine treatment partially restores urinary bladder function of streptozotocin diabetic rats.” Urol Int, 81(3):340-346. 2008.
  3. Kosan M, Tul M, Ozturk B, Hafez G, Inal G, Cetinkaya M. “Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity.” Urol Int, 80(2):193-200, 2008.
  4. Su X, Changolkar A, Chacko S, Moreland RS. “Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chainphosphorylation.” Am J Physiol Renal Physiol, 287(4):F690-699, 2004.
  5. Longhurst PA, Levendusky MC, Bezuijen MW. “Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction.” J Urol, 171(2 Pt 1):933-937, 2004.
  6. Barendrecht MM, Chichester P, Michel MC, Levin RM. Effect of short-term outlet obstruction on rat bladder nerve density and contractility. Auton Autacoid Pharmacol. 2007 Jan;27(1):47-53.
  7. Hammad FT. Electrical propagation in the renal pelvis, ureter and bladder. Acta Physiol (Oxf). 2015 Feb;213(2):371-83. doi: 10.1111/apha.12392.
  8. Michishita M, Yano K, Kasahara K, Tomita K, Matsuzaki O. Increased expression of 5-HT(2A) and 5-HT(2B) receptors in detrusor muscle after partial bladderoutlet obstruction in rats. Biomed Res. 2015;36(3):187-94. doi: 10.2220/biomedres.36.187.
A3. Ozturk B, Cetinkaya M, Oztekin V, Inal G, Adsan O, Ugurlu O, Ozden C, “Effects of forced diuresis achieved by oral hydration and oral diuretic administration on uroflowmetric parameters and clinical waiting time of patients with lower urinary tract symptoms”, Urol Int, 71: 22-25, 2003. DOI:10.1159/000071088
  1. Méndez-Rubio S, Chiarelli L, Salinas-Casado J, Cano S, Virseda-Chamorro M,Ramírez JC, Campanario F, Silmi-Moyano A. ["Post micturition residual; urodynamic"]. Actas Urol Esp, 34(4):365-371, 2010.
  2. Hinkel A, Noldus J, Palisaar R. “Urologic Emergencies in oncology.” Onkologe, 34(4):365-371, 2010.
  3. de Zeeuw S, van Mastrigt R. “Increased postvoid residual volume after measuring the isovolumetric bladder pressure using the noninvasive condom catheter method.” BJU Int, 100(6):1293-1297. 2007.
  4. van Mastrigt R, Pel JJ, Chung JW, de Zeeuw S. Development and application ofthe condom catheter method for non-invasive measurement of bladder pressure. Indian J Urol. 2009 Jan;25(1):99-104. doi: 10.4103/0970-1591.45546.
  5. Chandrapal j, Bowen RC, Patel DP, Le A, Hotaling JM, Southwick AW. High Rates of Inadequate Urine Volume Cause Failure of Clinic Based Uroflowmetry in Men with Lower Urinary Tract Symptoms. Urology Practice, 3(4):247-250. 2016. DOI:10.1016/j.urpr.2015.08.003
A5. Ugurlu O, Gonulalan U, Adsan O, Kosan M, Oztekin V, Cetinkaya M, “Effects of simultaneous transurethral resection of prostate and solitary bladder tumors smaller than 3 cm on oncologic results”, Urology, 70(1):55-9, 2007. DOI:10.1016/j.urology. 2007.03.015
  1. Luo S, Lin Y, Zhang W. “Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis.” J Endourol, 25(2):291-296, 2011.
  2. Jaidane M, Bouicha T, Slama A, Hmida W, Hidoussi A, Ben Sorba N, Mosbah F. “Tumor recurrence in prostatic urethra following simultaneous resection of bladder tumor and prostate: a comparative retrospective study.” Urology 75(6):1392-5, 2010.
  3. Singh V, Sinha RJ, Sankhwar SN. “Outcome of simultaneous transurethral resection of bladder tumor and transurethral resection of the prostate in comparison with the procedures in two separate sittings in patients with bladder tumor and urodynamically proven bladder outflow obstruction.” J Endourol, 23(12):2007-2011, 2009.
  4. Ham WS, Kim WT, Jeon HJ, Lee DH, Choi YD. “Long-term outcome of simultaneoustransurethral resection of bladder tumor and prostate in patients with nonmuscle invasive bladder tumor and bladder outlet obstruction.” J Urol, 181(4):1594-1599, 2009.
  5. Li Z, Hou R, Li J. The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms. Int Urol Nephrol April 2014, Volume 46, Issue 4, pp 691-694
  6. Li S, Zeng XT, Ruan XL, Wang XH, Guo Y, Yang ZH. Simultaneous transurethralresection of bladder cancer and prostate may reduce recurrence rates: Asystematic review and meta-analysis. Exp Ther Med. 2012 Oct;4(4):685-692
  7. Picozzi SC, Ricci C, Gaeta M, Casellato S, Bozzini G, Ratti D, Carmignani L. Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients. Int Urol Nephrol. 2012 Oct;44(5):1325-33. doi: 10.1007/s11255-012-0183-3.
  8. Park SH, Kim SI, Kim SJ.   Effects of Simultaneous Transurethral Resection of Non-Muscle-Invasive Bladder Cancer and Benign Prostatic Hyperplasia.   Korean J Urol. 2009 Jun;50(6):534-539.  DOI:10.4111/kju.2009.50.6.534
  9. Lee CH, Hwang TIS, Yeh CH. Simultaneous transurethral resection of a bladder tumor and benign prostatic hyperplasia: Four case reports and literature review.Urological Science. 2012 Mar; 23(1):31-33. DOI:10.1016/j.urols.2011.12.008
A6. Kosan M, Gonulalan U, Ugurlu O, Oztekin V, Akdemir O, Adsan O, “Testicular microlithiasis in patients with scrotal symptoms and its relationship to testicular tumors”, Urology, 70(6):1184-1186, 2007.  DOI:10.1016/j.urology.2007.07.049
  1. Tan IB, Ang KK, Ching BC, Mohan C, Toh CK, Tan MH. “Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review.” Cancer, 1;116(19):4520-4532, 2010.
  2. Aganovic L, Cassidy F. Imaging of the scrotum. Radiol Clin North Am. 2012Nov;50(6):1145-65. doi: 10.1016/j.rcl.2012.08.003.
  3. Richenberg J, Brejt N. Testicular microlithiasis: is there a need for surveillance in the absence of other risk factors? Eur Radiol. 2012 Nov;22(11):2540-6. doi: 10.1007/s00330-012-2520-4.
  4. Mullooly C, Hickerton B, Weston R, Woolley PD. Testicular microlithiasis: is it significant? Int J STD AIDS. 2012 Sep;23(9):620-2. doi: 10.1258/ijsa.2012.011444.
  5. Rahimi R, Foroughi AA, Haghpanah S, Bahmanyar M, Jelodari S, De Sanctis V, Karimi M. Incidence of testicular microlithiasis in patients with β-thalassemia major. Ann Hematol. 2015 Nov;94(11):1785-9. doi: 10.1007/s00277-015-2465-1.
  6. Baltogiannis D, Tsili A. Testicular microlithiasis: Clinical significance and review of the literature. Hell Urol. 2013; 27(3). DOI:10.19264/hj.v27i3.86
  7. Kühn AL, Scortegagna E, Nowitzki KM, Kim YH. Ultrasonography of the scrotum in adults. Ultrasonography. 2016 Jul;35(3):180-97. doi: 10.14366/usg.15075.
A7. Inal GH, Oztekin CV, Ugurlu O, Kosan M, Akdemir O, Cetinkaya M, “Sixteen gauge needles improve specimen quality but not cancer detection rate in transrectal ultrasound-guided 10-core prostate biopsies”, Prostate Cancer Prostatic Dis, 11(3):270-3, 2008. DOI:10.1038/pcan.2008.34
  1. Fajardo DA, Epstein JI. “Fragmentation of prostatic needle biopsy cores containing adenocarcinoma: the role of specimen submission.”  BJU Int, 105(2):172-175, 2010.
  2. Fiset PO, Aprikian A, Brimo F. Length of prostate biopsy cores: does it impact cancer detection? Can J Urol. 2013 Aug;20(4):6848-53.
  3. McCormack M, Duclos A, Latour M, McCormack MH, Liberman D, Djahangirian O,Bergeron J, Valiquette L, Zorn K. Effect of needle size on cancer detection, pain, bleeding and infection in TRUS-guided prostate biopsies: A prospective trial. Can Urol Assoc J. 2012 Apr;6(2):97-101. doi: 10.5489/cuaj.11169.
  4. Cicione A, Cantiello F, De Nunzio C, Tubaro A, Damiano R. Prostate biopsy quality is independent of needle size: a randomized single-center prospective study. Urol Int. 2012;89(1):57-60. doi: 10.1159/000339250.
  5. Durmus T, Goldmann U, Baur AD, Huppertz A, Schwenke C, Hamm B, Franiel T.MR-guided biopsy of the prostate: comparison of diagnostic specimen quality with 18 G and 16 G biopsy needles. Eur J Radiol. 2013 Dec;82(12):e749-54. doi: 10.1016/j.ejrad.2013.08.020.
  6. Lee S, Jeong SJ, Hwang SI, Hong SK, Lee HJ, Byun SS, Choe G, Lee SE. Clinical value of core length in contemporary multicore prostate biopsy. PLoS One. 2015Apr 14;10(4):e0123704. doi: 10.1371/journal.pone.0123704.
  7. Cicione A, Cantiello F, De Nunzio C, Tubaro A, Damiano R. Needle biopsy size and pathological Gleason Score diagnosis: No evidence for a link. Can Urol Assoc 2013 Sep-Oct;7(9-10):E567-71. doi: 10.5489/cuaj.311.
  8. Shida Y, Hakariya T, Takehara K, Onita T, Miyata Y, Sakai H. Comparison Between a Combined Transrectal and Transperineal Approach and a Transrectal Approach for Prostate Rebiopsy. Anticancer Res. 2016 Sep;36(9):4685-90.
  9. Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, WagenlehnerFM. Prostate Biopsy-related Infection: A Systematic Review of Risk Factors,Prevention Strategies, and Management Approaches. Urology. 2016 Dec 19. pii:S0090-4295(16)30953-0. doi: 10.1016/j.urology.2016.12.011.
A9. Ozden C, Oztekin CV, Ugurlu O, Gokkaya S, Yaris M, Memis A, “Correlation between upgrading of prostate biopsy and biochemical failure and unfavorable pathology after radical prostatectomy”. Urol Int, 83:146-150, 2009. DOI:10.1159/000230014
  1. Lallas CD, Pe ML, Thumar AB, Chandrasekar T, Lee FC, McCue P, Gomella LG,Trabulsi EJ. “Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy.” BJU Int, 107(7):1136-1140, 2011.
  2. Colleselli D, Schilling D, Lichy MP, Hennenlotter J, Vogel UH, Krueger SA,Kuehs U, Schlemmer HP, Stenzl A, Schwentner C. “Topographical sensitivity andspecificity of endorectal coil magnetic resonance imaging for prostate cancerdetection.” Urol Int, 84(4):388-394, 2010.
  3. Reis LO, Zani EL, Freitas LL, Denardi F, Billis A. Higher prostate weight is inversely associated with Gleason score upgrading in radical prostatectomy specimens. Adv Urol. 2013;2013:710421. doi: 10.1155/2013/710421.
  4. Bostwick DG, “Pathological Implications of Prostate Biopsy” in “Prostate Cancer Diagnosis”. 2012; 189-225. DOI:10.1007/978-1-62703-188-2_16.
  5. Winters BR, Wright JL, Holt SK, Lin DW, Ellis WJ, Dalkin BL, Schade GR. Extreme Gleason Upgrading From Biopsy to Radical Prostatectomy: A Population-based Analysis. Urology. 2016 Oct;96:148-155. doi: 10.1016/j.urology.2016.04.058.
  6. DEMİRELHC, AKDEMİRAÖ, ÖZTEKİN ÇV, GÖKKAYA CS, ÇETİNKAYA M, MEMİŞ A. Ortadoğu Medical Journal. 2012;4(2):49-52.
A10. Ugurlu O, Yaris M, Oztekin CV, Kosan TM, Adsan O, Cetinkaya M, “Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: A prospective randomized controlled trial” Urol Int, 84:185-90, 2010. DOI:10.1159/000277596
  1. Sfanos KS, De Marzo AM. “Prostate cancer and inflammation: the evidence.” Histopathology, 60(1):199-215, 2012.
  2. Akduman B, Akduman D, Tokgöz H, Erol B, Türker T, Ayoğlu F, Mungan NA. “Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms.” Urology, 78(2):250-255, 2011.
  3. Shinohara DB, Vaghasia AM, Yu SH, Mak TN, Brüggemann H, Nelson WG, De MarzoAM, Yegnasubramanian S, Sfanos KS. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate. 2013 Jun;73(9):1007-15. doi: 10.1002/pros.22648.
  4. Yang L, Zhu Y, Tang Z, Chen Y, Gao L, Liu L, Han P, Li X, Wei Q. Antibiotics may not decrease prostate-specific antigen levels or prevent unnecessary prostate biopsy in patients with moderately increased prostate-specific antigen levels: A meta-analysis. Urol Oncol. 2015 May;33(5):201.e17-24. doi: 10.1016/j.urolonc.2015.02.001.
  5. Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA. SIGIRR/TIR8, an importantregulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemicalrecurrence after prostatectomy in low-grade prostate carcinomas. Hum Pathol. 2015Nov;46(11):1744-51. doi: 10.1016/j.humpath.2015.07.015.
  6. Jones, Kia J., "The Contribution of Inflammatory Cells to the Progression of Prostate Cancer" (2016). Electronic Theses & Dissertations Collection for Atlanta University & Clark Atlanta University. 26.
  7. Staibano S. “Molecular Determinants of Cancer-Related Inflammation” in “Prostate cancer: Shifting from morphology to biology”, 2013;45-56. DOI:10.1007/978-94-007-7149-9_2
  8.  Yu Fan, Guo D,Wei Q, Tang Z, Cao DH, Yang Lu, Liu LR, Liu ZH, Li X, Xue WB, Lei JH. Antibiotics has incapability of reducing unnecessary prostate biopsies: a meta-analysis involving 2,035 patients. Int J Clin Exp Med. 2016;9(2):4658-73.
A11. Akdemir AO, Ozden C, Öztekin ÇV, Aktas BK, Cetinkaya M, Memis A, Doluoglu OG, “Stage-by-Stage Effects of Surgical Margin Status on Biochemical Failure after Radical Prostatectomy in Patients with Clinically Localized Prostate Cancer”, Urol Int, 86:156-160, 2011.     DOI:10.1159/000322840
  1. Huri E, Aydoğmuş Y, Doluoğlu ÖG, Dadalı M, Karakan T, Emir L, Germiyanoğlu C. Effect of positive surgical margins on biochemical failure, biochemical recurrence-free survival, and overall survival after radical prostatectomy: Median long-term results. Kaohsiung J Med Sci, 2014.
  2.  Ozden C, Aktas BK, Bulut S, Erbay G, Tagci S, Gokkaya CS, Baykam MM, Memis A.  Effect of age on biochemical recurrence after radical prostatectomy. Kaohsiung J  Med Sci. 2017 Feb;33(2):91-95. doi: 10.1016/j.kjms.2016.11.002.
A12. Akdemir AO, Demirturk K, Karabakan M, Öztekin ÇV, Abdulkadir NA, Cetinkaya M, Gur S, Hellstrom JG, “Imatinib Mesylate (Gleevec) as protein-tyrosine kinase inhibitor elicits smooth muscle relaxation in isolated human prostatic tissue”, Urology, 78:968.e1-968.e6, 2011.    DOI:10.1016/j.urology.2011.06.033
  1. Nina A. Maihöfer, Said Suleiman, Daniela Dreymüller, Paul W. Manley, Rolf Rossaint, Stefan Uhlig, Christian Martin† and Annette D. Rieg† Imatinib relaxes the pulmonary venous bed of guinea pigs. Respiratory Research 2017, 18:32,  DOI: 10.1186/s12931-017-0514-0
  2. Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ. Imatinibattenuates monocrotaline pulmonary hypertension and has potent vasodilatoractivity in pulmonary and systemic vascular beds in the rat. Am J Physiol HeartCirc Physiol. 2013 Nov 1;305(9):H1288-96. doi: 10.1152/ajpheart.00329.2013.
  3. Gur S, Sikka SC, Abdel-Mageed AB, Abd Elmageed ZY, Rezk B, Pankey E, Kadowitz  PJ, Hellstrom WJ. Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new  RTK targets. Urology. 2013 Sep;82(3):745.e11-6. doi: 10.1016/j.urology.2013.04.030.
  4. Pankey EA, Lasker GF, Gur S, Hellstrom WJ, Kadowitz PJ. Analysis of erectile responses to imatinib in the rat. Urology. 2013 Jul;82(1):253.e17-24. doi: 10.1016/j.urology.2013.04.009.
  5. Gur S, Sikka SC. The characterization, current medications, and promising therapeutics targets for premature ejaculation. Andrology. 2015 May;3(3):424-42.  doi: 10.1111/andr.12032.
A16. Öztekin ÇV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, Hellstrom WJ, “Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5-Alpha Reductase Inhibitor Therapy”, J Sex Med, 9(7):1773-1781, 2012.  DOI:10.1111/j.1743-6109.2012.02759.x
  1. Un O, Yilmaz D, Bayatli N, Kaya E, Gur S. L-arginine and tetrahydrobiopterin,  but not sodium nitrite partially restored erectile dysfunction in aged rats. Aging Male. 2014 Dec;17(4):248-55. doi: 10.3109/13685538.2014.921150.
  2. Traish, A.M. “The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being” Curr Sex Health Rep (2015) 7: 210. doi:10.1007/s11930-015-0061-y
  3. Traish AM, Mulgaonkar A, Giordano N.   The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression.   Korean J Urol. 2014 Jun;55(6):367-379.   https://doi.org/10.4111/kju.2014.55.6.367
  4. Gur S, Sikka SC. The characterization, current medications, and promising therapeutics targets for premature ejaculation. Andrology. 2015 May;3(3):424-42. doi: 10.1111/andr.12032. Review. PubMed PMID: 25951512.
  5. Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ. Imatinibattenuates monocrotaline pulmonary hypertension and has potent vasodilatoractivity in pulmonary and systemic vascular beds in the rat. Am J Physiol HeartCirc Physiol. 2013 Nov 1;305(9):H1288-96. doi: 10.1152/ajpheart.00329.2013.
  6. Irwig MS. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects. J Clin Psychiatry. 2012 Sep;73(9):1220-3. doi: 10.4088/JCP.12m07887.
  7. Traish AM. 5α-reductases in human physiology: an unfolding story. Endocr Pract. 2012 Nov-Dec;18(6):965-75. doi: 10.4158/12108.RA.
  8. Zhang MG, Wang XJ, Shen ZJ, Gao PJ. Long-term oral administration of 5α-reductase inhibitor attenuates erectile function by inhibiting autophagy and promoting apoptosis of smooth muscle cells in corpus cavernosum of aged rats. Urology. 2013 Sep;82(3):743.e9 -15. doi: 10.1016/j.urology.2013.02.045.
  9. Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know? Rev Endocr Metab Disord. 2015 Sep;16(3):177-98. doi: 10.1007/s11154-015-9319-y.
  10. Irwig MS. Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men. Sex Med Rev. 2014 Jan;2(1):24-35. doi: 10.1002/smrj.19.
  11. Irwig MS. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2015 Jun;22(3):248-53. doi: 10.1097/MED.0000000000000158.
  12. Traish AM, Haider KS, Doros G, Haider A. Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Horm Mol Biol Clin Investig. 2015 Sep;23(3):85-96. doi: 10.1515/hmbci-2015-0015.
  13. Trost L, Saitz TR, Hellstrom WJ. Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review. Sex Med Rev. 2013 May;1(1):24-41. doi: 10.1002/smrj.3.
  14. Liu L, Zhao S, Li F, Li E, Kang R, Luo L, Luo J, Wan S, Zhao Z. Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Reviewof Randomized Controlled Trials. J Sex Med. 2016 Sep;13(9):1297-310. doi: 10.1016/j.jsxm.2016.07.006.
  15. Gupta K, Yezdani M, Sotelo T, Aragon-Ching JB. A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2015;24(8):1059-73. doi: 10.1517/13543784.2015.1048333.
  16. Arias-Santiago S, Camacho-Martínez FM. Adverse Effects of 5-Alpha ReductaseInhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006.
  17. Xie, D., Chughtai, B., Elterman, D.S. et al. Curr Bladder Dysfunct Rep (2013) 8: 229. doi:10.1007/s11884-013-0187-6
A15. Doluoglu OG, Gokkaya CS, Aktas BK, Öztekin ÇV, Bulut S, Memis A, Cetinkaya M, “Impact of asymptomatic prostatitis on re-operations due to urethral stricture or bladder neck contracture developed after TUR-P.”, Int Urol Nephrol, 44(4):1085-1090, 2012. DOI:10.1007/s11255-012-0127-y
  1. Leyh  H , Necknig U.  Transurethrale Resektion der Prostata. Der Urologe. May 2014, Volume 53, Issue 5, pp 699-705
  2. Qian X, Kong X, Qian Y, et al. Therapeutic efficacy of Cernilton in benign prostatic hyperplasia patients with histological prostatitis after transurethral resection of the prostate. International Journal of Clinical and Experimental Medicine. 2015;8(7):11268-11275.
  3. Tao, Huang, Jiang, Yu Yong, Jun, Qi, Ding, Xu, Jian, Duan Liu, Jie, Ding, & Ping, Zhu Yu. (2016). Analysis of risk factors leading to postoperative urethral stricture and bladder neck contracture following transurethral resection of prostate. International braz j urol, 42(2), 302-311. DOI: 10.1590/S1677-5538.IBJU.2014.0500
A18. Gökkaya CS, Öztekin ÇV, Özden C, Öztürk E, Aktaş BK, Memiş A, “Insulin resistance impairs response to doxazosin therapy in men with benign prostatic hyperplasia”, Turk J Med Sci, 43(1):1-5, 2013. DOI: 10.3906/sag-1203-90
  1. Umul M, Altay AM, Bademkıran F, Turna B, Semerci MB, Apaydın E, Çıkılı N. The relationship between lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: the role of autonomic hyperactivity. Turk J Med Sci 2014; 44(4): 681-686.
  2. Altın S, Ozan T, İlhan S, İlhan N, Onur R. Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study. Turkish Journal of Urology. 2015;41(3):125-131. doi:10.5152/tud.2015.89656
A20. Gökkaya CS,Özden C, Aktaş BK,Demirel HC, Güzel Ö, Karabakan M, Erkmen AE, Öztekin ÇV, Memiş A, “The Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms in Females”, Turk J Med Sci, 43(3):400-404, 2013. DOI: 10.3906/sag-1206-66 
  1. Bunn, F., Kirby, M., Pinkney, E., Cardozo, L., Chapple, C., Chester, K., Cruz, F., Haab, F., Kelleher, C., Milsom, I., Sievart, K. D., Tubaro, A. and Wagg, A. (2015), Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. Int J Clin Pract, 69: 199–217. doi:10.1111/ijcp.12518
A21. Öztekin ÇV, Gür S, Abdulkadir NA, Kartal M, Karabakan M, Akdemir AÖ, Gökkaya CS, Çetinkaya M, “Analysis of pomegranate juice components in rat corpora cavernosal relaxation”, Int J Impot Res, 2013.DOI:10.1038/ijir.2013.33 [1 Ağustos 2013 tarihinde online olarak yayınlanmıştır.]
  1. E Onal, D Yilmaz, E Kaya, T Bastaskın, N Bayatlı and S Gur, Pomegranate juice causes a partial improvement through lowering oxidative stress for erectile dysfunction in streptozotocin-diabetic rat, International Journal of Impotence Research (2016) 28, 234–240; doi:10.1038/ijir.2016.34
  2. Gur, S., Rezk, B. M., Abd Elmageed, Z. Y., Kadowitz, P. J., Sikka, S. C. and Hellstrom, W. J. G. (2016), Characterisation of pomegranate juice effects on human corpus cavernosum. Andrologia. doi:10.1111/and.12712
  3. Eyad M. MALLAH, Walid S.A. RAYYAN, Wael A.A. DAYYIH, Feras D. ELHAJJI, Kenza A. MANSOUR, Ibrahim S. AL-MAJALI, Tawfiq A. ARAFAT, ”Dose-Dependent Synergistic effect of Pomegranate Juice on the Bioavailability of Sildenafil in Rats by Using HPLC Method” Lat. Am. J. Pharm. 35 (6): 1277-84 (2016)
A23. Ercan M, Akbulut ED, Abuşoğlu S, Yılmaz FM, Oğuz EF, Topçuoğlu C, Öztekin ÇV, Boğdaycıoğlu N. “Stability of urine specimens stored with and without preservatives at room temperature and on ice prior to urinalysis.” Clin Biochem. 2015 May 27. pii: S0009-9120(15)00207-6. DOI:10.1016/j.clinbiochem.2015.05.016
  1. Ekşioğlu MK1, Madenci ÖÇ1, Yücel N1, Elçi A2, Turhan B2, Orhan G2, Orçun A1.The effectiveness of BD Vacutainer® Plus Urinalysis Preservative Tubes in preservation of urine for chemical strip analysis and particle counting. Biochem Med (Zagreb). 2016;26(2):224-32. doi: 10.11613/BM.2016.024.
  2. Joris R. Delanghe, ⁎, Marijn M. Speeckaert, Preanalytics in urinalysis, Clinical Biochemistry 49 (2016) 1346–1350. http://dx.doi.org/10.1016/j.clinbiochem.2016.10.016 0
D16.Özer Güzel, Çetin Volkan Öztekin, Alp Özgür Akdemir, Mehmet Karabakan, Mesut Çetinkaya Giant Fecaloma Leading to Bilateral Ureterohydronephrosis Erciyes Med J 2015; 37(3): 110-2 • DOI: 10.5152/etd.2015.7161
  1. Kim, J., Yoon, H. and Eom, K. (2017), IMAGING DIAGNOSIS — RADIOGRAPHY, ULTRASONOGRAPHY, AND COMPUTED TOMOGRAPHY OF A GIANT FECALOMA CAUSING STERCORAL PERFORATION OF THE COLON IN A DOG WITH A PROSTATIC ABSCESS. Vet Radiol Ultrasound. doi:10.1111/vru.12476

Çetin Volkan ÖZTEKİN ile İlgili Haberler

© Copyright 2018 | Near East Technology